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1CHAPTER I
INTRODUCTION
     Intercellular communication is absolutely required for proper cell fate
specification during early embryogenesis.  This process often involves secreted
ligands that travel from the source of protein production to responding cells
where they bind to their cognate receptors on the cell membrane.  This ligand-
receptor interaction results in the activation of intracellular signal transduction
programs that lead to the expression of a specific collection of genes that are
responsible for cell fate determination.  Although numerous intercellular signaling
pathways have been identified that play a role in cell fate specification, my
studies have focused on the Transforming Growth Factor beta (TGF)
superfamily and specifically two family members, Nodal and Lefty.  Nodal
signaling has emerged as a crucial and evolutionary conserved dose-dependent
inducer of mesendoderm during gastrulation, and is required at later stages for
left-right (L-R) axis specification.  Many recent data suggest that a precise
balance between positive and negative influences is required to generate a
proper Nodal activity gradient during embryogenesis.  The experiments
described in this thesis demonstrate that Lefty, the primary Nodal antagonist,
undergoes several post-translational modifications and that some of these
modifications are required for Nodal-blocking function.  A brief introduction will
include information about morphogen activity gradients and the mechanisms that
2generate or regulate such gradients.  This will be followed by a description of
Nodal signaling and the role of Lefty molecules in modulating Nodal activity.
Finally, I will end with a brief description on the structure of Lefty-related
molecules and describe the types of post-translational processing that Lefty may
undergo.
Nodal ligands as morphogens
Morphogen activity gradients
     A morphogen is defined as a secreted signaling molecule that patterns a field
of cells by activating characteristic sets of target genes in a concentration-
dependent manner.  Morphogens are generally thought of as being distributed
along a gradient with a higher concentration near the source of protein
production (Green, 2002).  Responding cells then perceive their position within
the morphogen gradient in order to determine the appropriate developmental
fate.  There is developing evidence that morphogen-like characteristics are
carried by proteins in the Hedgehog, Wingless, and TGF families (Tabata and
Takei, 2004).  Recently, FGF (Fibroblast growth factor) family members have
also been shown to have morphogen-like behaviors.  A good example of the
concentration-dependent dose response relationship was shown by recent
studies on FGF2, where it was demonstrated that different concentrations of the
FGF2 protein were able to induce different levels of Hox-c expression in spinal
motor neurons (Liu et al., 2001).  In addition, Dubrulle and Pourquie (2004) have
3demonstrated that a gradient of FGF8 protein results in a graded response in the
phosphorylation of Akt, a well-known downstream target of FGF signaling
(Schlessinger, 2000).
     Since the action of a single morphogen can lead to the specification of
multiple cell fates, the embryo needs to have in place mechanisms that not only
generate but strictly control morphogen gradient formation.  Intense research in a
multitude of organisms has begun to dissect these mechanisms.  One way to
control the formation of these gradients would be to regulate the transcription and
translation of both the morphogen and its extracellular antagonist.  A good
example of translational control was demonstrated by the fact that fgf2 antisense
RNA transcripts seem to govern the amount of protein produced from translation
of fgf2 mRNA (Li and Murphy, 2000).  The stability or the rate of degradation of
the mRNAs encoding these morphogens is another method to control the activity
gradient.  This mechanism is the result of the binding of trans-acting proteins and
RNAs to cis-elements in the mRNA message to either promote or inhibit
degradation by RNases (Dibrov et al., 2006). In vertebrate axis elongation, the
role of mRNA degradation, in particular fgf8, was shown to contribute to
formation of the FGF8 protein gradient (Dubrulle and Pourquie, 2004).
     Another way to achieve the generation of a morphogen gradient would be to
control the amount of extracellular secreted ligand available for effective
signaling, which could be done by modulating the level of endocytic clearance
from the extracellular compartment (Cadigan, 2002).  Experiments using
dynamin mutant clones in Drosophila wing imaginal discs, and overexpression of
4dominant negative components of the endocytic pathway in zebrafish, have
demonstrated that endocytosis controls the amount of Wingless and FGF8
available for signaling (Scholpp and Brand, 2004; Marois et al., 2006).  However,
the role of endocytosis in generating the Dpp (Decapentaplegic) gradient in
Drosophila wing imaginal discs is controversial.  Entchev et al. (2000) suggested
that Dynamin-mediated endocytosis was required for the long-range movement
of Dpp while Belenkaya et al. (2004) reported that Dpp movement was
independent of Dynamin function.
     Interactions with cell surface proteins, such as heparan sulfate proteoglycans
(HSPGs), have been shown to both positively and negatively alter the distance
that morphogens move from the source of their production (Ohkawara et al.,
2002; Belenkaya et al., 2004; Han et al., 2004; Lin, 2004).  This interaction is
thought to occur electrostatically, through the basic amino acids of HSPG-
interacting proteins associating with the negatively charged heparan sulfate (Irie
et al., 2003).  For Hedgehog, Wg, and Dpp, HSPGs have been demonstrated to
permit the long-range movement of these molecules in Drosophila wing imaginal
discs (Belenkaya et al., 2004; Takei et al., 2004).  The interaction between
HSPGs and BMP-4 has been tested in Xenopus embryos (Ohkawara et al.,
2002).  When three basic amino acids (R-K-K) were deleted from the N-terminus
of the ligand domain of BMP-4 (-BMP-4), the signaling range of -BMP-4 was
increased compared to wild-type BMP-4.  This increase was caused by -BMP-4
having a lower capacity to bind heparin compared to the wild-type molecule.  It
has been postulated, based on the data presented above, that extracellular
5“molecular highways” are generated by HSPGs that facilitate the long-range
movement of morphogens (Strigini, 2005).  This model suggests that
morphogens are effectively transferred from one sugar chain to another sugar
chain on the large proteoglycans, with a net movement of morphogen down the
concentration gradient (Strigini, 2005).
Cleavage and post-translational modification of extracellular signaling
molecules
     Members of the subtilisin-like proprotein convertase family (SPC) are calcium-
dependent serine endoproteases that recognize the R-X-X-R motif found in many
intercellular signaling molecules, including TGF superfamily members
(Nakayama, 1997; Molloy et al., 1999).  There are seven vertebrate family
members, of which SPC1, SPC4, and SPC6 have been shown to mediate
cleavage of both Lefty and Nodal in several transfected cell lines (Ulloa et al.,
2001; Beck et al., 2002; Sakuma et al., 2002; Nelsen et al., 2005).  The tissue
distribution and even the intracellular localization seem to vary among the
various SPCs.  The prevailing idea used to be that SPCs functioned
intracellularly within the source cells to process the precursors of peptide
hormones and other proteins into their biologically active forms (Bergeron et al.,
2000).  Recently, however, several reports suggested that SPCs may also
function at the cell surface, or even become secreted into the extracellular milieu
and, therefore, act non-cell-autonomously on proproteins secreted from adjacent
or nearby cells.  For example, endogenous SPC6A has been detected at the
surface in adult mouse liver, duodenum, and jejunum (Nour et al., 2005).
6Another relevant example came from work by Daniel Constam and colleagues.
They demonstrated that, at embryonic day 5.5, mouse nodal and spc1/spc4 were
expressed in the epiblast and extraembryonic ectoderm, respectively (Beck et al.,
2002).  The model arising from these findings is that proprotein cleavage may
occur in the extracellular space (Beck et al., 2002).  In agreement with this
supposition, an artificial system was used to demonstrate that cleavage of mouse
Nodal and Lefty could occur by secreted SPCs secreted from COS1 (Beck et al.,
2002).  In this system, conditioned medium from COS1 cells expressing Lefty
and Nodal proproteins were incubated with soluble SPCs, which were secreted
into the condition medium by COS1 cells expressing spc1, spc4, and spc6 (Beck
et al., 2002).
     In addition to control being exerted at the level of proprotein cleavage,
secondary modifications of the core polypeptide could easily be thought of as
modifying interactions with extracellular components and with the cognate
receptors.  Carbohydrate addition, such as N-linked glycosylation, can affect a
myriad of biological processes.  It may stabilize the protein against denaturation
and proteolysis, influence protein folding, increase protein solubility, and provide
structural rigidity to the core protein (Helenius and Aebi, 2004).  The presence of
N-linked glycans can increase the secretion and biological activity of several
TGFrelated members.  For example, both TGF1 and TGF2 contain several
glycosylation motifs in the prodomain and require N-linked glycans for efficient
secretion of the ligand into the culture medium (Sha et al., 1989; Brunner et al.,
1992; Lopez et al., 1992).  Since its discovery, mouse Nodal has been
7notoriously difficult to detect when secreted from several mammalian cell lines,
but the addition of an artificial glycosylation motif into the ligand domain
increased its steady-state level of protein accumulation, signaling strength, and
range of signaling compared to the wild-type protein (Le Good et al., 2005).
These results suggest that glycosylation may play important functions in
controlling secretion and stability of TGF molecules.
Nodal signaling in vertebrate embryos
     Although Nodal signaling seems to involve a specific complex of TGF
receptors and cofactors (see below), ligand maturation and initiation of the
signaling cascade follow the general rules of all TGF molecules. Nodal is initially
synthesized as a large pre-proprotein with an N-terminal hydrophobic signal
sequence for secretory pathway targeting, a prodomain, and a C-terminal mature
ligand domain (Kingsley, 1994).  As described above, maturation of the pre-
proprotein involves proteolytic cleavage at the dibasic R-X-X-R motif by SPCs to
release the mature ligand from the prodomain in the form required to engage the
receptor complex for active signaling (Kingsley, 1994; Nakayama, 1997; Cui et
al., 1998; Constam and Robertson, 1999; Molloy et al., 1999; Ulloa et al., 2001;
Beck et al., 2002; Sakuma et al., 2002; Ben-Haim et al., 2006).  Most TGF
family members contain 7-9 conserved cysteine residues of which six are
involved in generating a structure referred to as a “cysteine knot”.  One of these
cysteines will form a disulfide bond between two monomers to generate the
biologically active homodimer or heterodimer (Sun and Davies, 1995).  These
8primary structure characteristics (dibasic cleavage motif and 7 cysteine residues)
are contained within the amino acid residues of mouse Nodal and several of the
Xenopus Nodal-related proteins (Xnr), such as Xnrs1, 2, 4, 5, and 6 (Conlon et
al., 1994; Jones et al., 1995; Joseph and Melton, 1997; Takahashi et al., 2000).
     In order to initiate downstream signaling, the Nodal dimer engages a receptor
complex consisting of type I and type II Activin receptors that both possess
intracellular serine/threonine kinase domains (Fig. 1.1) (Massague, 1998; Schier,
2003).  Biochemical and genetic evidence has demonstrated that, unlike Activin,
for example, the activation of Nodal signaling also requires the presence of the
EGF-CFC co-receptor (Gritsman et al., 1999; Whitman, 2001; Yeo and Whitman,
2001; Schier, 2003; Dorey and Hill, 2006; Onuma et al., 2006).  The downstream
result of Nodal-receptor complex interaction is, similar to Activin, however,
involving the phosphorylation of either Smad2 or Smad3, which then associates
with Smad4 (Schier, 2003).  The activated Smad complex becomes translocated
to the nucleus in association with a more sequence-selective DNA-binding co-
factor, such as FoxH1, where it acts to induce the transcription of Nodal-target
genes (Whitman, 2001; Schier, 2003).
9Figure 1.1 Nodal signal transduction pathway.  Binding of the Nodal dimer to
the ActRIIA/B type II receptor (1) in combination with the Alk4 type I receptor (2)
and the EGF-CFC co-receptor leads to formation of an activated receptor
complex (3) and phosphorylation of the type I receptor (4).  Thus activated, the
type I receptor phosphorylates Smad 2 or Smad3 (5), allowing this complex to
associate with Smad4 (6).  The activated Smad complex translocates to the
nucleus (7) and associates with DNA-binding partners, such as FoxH1 (8)
resulting in transcription of downstream target genes (9). Modified from
Massague, 1998.
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     There are several proteins that both positively and negatively influence Nodal
signaling during embryogenesis.  Some of these proteins have a broad effect for
the various TGF family members, whereas some appear relatively restricted in
affecting Nodal/Activin signaling. For example, Smad6 and Smad7 are proteins
utilized by both TGF and Nodal pathways to attenuate signaling by
competitively binding to activated receptor complexes and recruiting E3-ubiquitin
ligases to target the receptors for degradation (Kavsak et al., 2000; Suzuki et al.,
2002).  An additional function of Smad6 and Smad7 includes binding to Smad4
to prevent Smad2/3-Smad4 complex formation (Massague, 1998).  Processes
that induce the degradation of Smad4 can curtail TGF signaling.  For example,
Ectodermin, a RING-type ubiquitin ligase, is responsible for terminating TGF
signaling by catalyzing the addition of poly-ubiquitin to Smad4, leading to its
proteosome-mediated degradation (Dupont et al., 2005).  Proteins that remove
phosphate moieties from Smads can also attenuate signaling.  Recently, several
phosphatases, such as PPM1A and small C-terminal domain phosphatases,
have been found to reside in the nucleus and dephosphorylate Smad proteins,
leading to termination of signaling (Duan et al., 2006; Knockaert et al., 2006; Lin
et al., 2006; Sapkota et al., 2006; Wrighton et al., 2006).  On the other hand,
proteins that inhibit the function or induce the degradation of such negative
regulators of signal transduction can enhance TGF signaling.  For example,
Arkadia, a RING domain E3-ubiquitin ligase, can induce the proteosome-
dependent degradation of several negative regulators (Smad7, SnoN, and c-Ski)
11
of the TGF pathway and leads to enhanced signaling (Liu et al., 2006; Nagano
et al., 2007).
     As compared to the proteins discussed above, which seem to regulate TGF
pathways, there are several molecules that appear to modulate only
Nodal/Activin signaling.  Recently, Suri et al. (2005) and Mir et al. (2007) used
subtractive hybridization and microarray technologies to discover factors that
were down-regulated by Xnr/Activin signaling.  Both groups independently
identified the transcription factor gene Xema/Foxi1e and showed that it was
expressed in the animal region, where it functioned to suppress mesendoderm
formation.  Data gathered using both transactivation domain (VP16) or
repression domain (EnR) fusion proteins suggested that Foxi1e either directly or
indirectly stimulated the transcription of as yet unknown inhibitors of
mesendodermal fates (Suri et al., 2005).  The experimental findings to date
suggest that it acts as an endogenous suppressor of mesodermalization to force
the embryo to overcome a “mesoderm induction threshold”, thus ensuring correct
apportioning of tissue fates across the embryo.
Nodal, an inducer of mesendoderm
     The formation of the three primary germ layers, ectoderm, mesoderm, and
endoderm, is a critical patterning event of early embryogenesis, which sets the
stage for all future inductive events.  Early tissue grafting experiments by
Nieuwkoop and others showed that the mesoderm induction process results from
signals that emanate from the vegetal region to specify the overlying equatorial
12
region (Harland and Gerhart, 1997).  Subsequently, heterochronic tissue grafts
suggested that the endogenous mesoderm-inducing factor was a maternally
supplied protein or RNA (Harland and Gerhart, 1997).  At the time of these
experiments, the only inducer that fulfilled this requirement was Activin
(Asashima et al., 1990; Slack, 1990; Smith et al., 1990).  The subsequent
discovery of Vg1 mRNA, localized to the vegetal hemisphere in Xenopus
embryos, suggested that this TGF molecule was the long-sought-after inducer
(Weeks and Melton, 1987; Pondel and King, 1988).  Further experiments,
however, cast doubt on the role of both Activin and Vg1 in patterning the early
embryo.  Whereas overexpression of many TGF members induced mesoderm,
injection of Vg1 RNA did not (Tannahill and Melton, 1989) and strong inducing
properties of the Vg1 ligand were only seen when it was fused to a BMP
prodomain region (Thomsen and Melton, 1993).  Moreover, the endogenous
ligand domain of Vg1 could not be detected in embryos (Tannahill and Melton,
1989).  Recently, Janet Heasman and coworkers have made clear progress
toward resolving the role of Vg1 in embryonic patterning.   They discovered a
new isoform of Vg1, which contained a serine instead of a proline at amino acid
position 20.  This version had mesoderm inducing properties when
overexpressed in Xenopus embryos without the need to resort to the chimeric
prodomain/ligand approach referenced above (Birsoy et al., 2005; Birsoy et al.,
2006).  Evidence against Activin being an endogenous mesoderm inducer came
from genetic studies in mouse, in which activin A and activin B have been
mutated using homologous recombination techniques.  These homozygous null
13
mutant mice progressed normally through embryogenesis and contained
normally patterned mesoderm (Matzuk et al., 1995).  The role of Activin in
patterning the early embryo has been further clouded by two recent reports from
the laboratory of James Smith (Piepenburg et al., 2004; Ramis et al., 2007).  In
the first report, morpholino-mediated knockdown was concluded to show that
endogenous Activin was involved in mesoderm induction, as rt-PCR assays
showed that there was a reduction in the expression of mesodermal marker
genes within the embryo (Piepenburg et al., 2004).  Later experiments using
microarray analysis of embryos injected with the same morpholino targeted
against activin (described above) suggested that Activin signaling functioned to
control cell division (Ramis et al., 2007).  It is puzzling why the same morpholino
used in the same lab would generate data suggesting different functions of
Activin.
     The initial evidence that Nodal was the endogenous mesendoderm inducer
came from a mouse mutant, 413.d, that carries a retroviral insertion-mediated
inactivation of the nodal locus (Zhou et al., 1993; Conlon et al., 1994).  The
homozygous mutant mice fail to form a primitive streak and lack most mesoderm
and endoderm.  Following the isolation of Nodal in mice, Nodal-related proteins
have been identified in all vertebrate species.  In Xenopus, six nodal-related
proteins (Xnrs1-6) have been isolated, of which Xnrs1, 2, 4, 5, and 6 have been
shown to possess mesoderm-inducing activities (Jones et al., 1995; Smith et al.,
1995; Joseph and Melton, 1997; Takahashi et al., 2000).  Xnr3 is more divergent,
as it lacks the last of the seven cysteines and has a serine instead of a glycine
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between the second and third cysteines (Ezal et al., 2000).  Probably, the most
important function for Xnr3 is its role in regulating convergent and extension
movements in Xenopus (Yokota et al., 2003).  Squint (sqt), cyclops (cyc), and
southpaw (spaw) are the three nodal-related genes known in zebrafish (Erter et
al., 1998; Sampath et al., 1998; Long et al., 2003).  In gain-of-function studies,
mouse Nodal, Cyc, Sqt and Xnrs1, 2, 4, 5, and 6 can dose-dependently induce
mesoderm when overexpressed in Xenopus animal caps (Jones et al., 1995;
Joseph and Melton, 1997; Erter et al., 1998; Sampath et al., 1998; Takahashi et
al., 2000). Consistent with the loss-of-function data from mouse, null mutations in
cyc and sqt produce a highly mesoderm-deficient embryo (Feldman et al., 1998).
Similarly, loss-of-function experiments in Xenopus revealed the conserved
mesoderm-inducing activities of Xnrs.  Overexpression of Xnr-specific inhibitors,
such as cleavage-mutant Xnr2, a Nodal-specific truncation version of the
secreted antagonist Cerberus-short, as well as Lefty, resulted in reduction or
elimination of mesendodermal derivatives (Osada and Wright, 1999; Agius et al.,
2000; Cheng et al., 2000; Onuma et al., 2002).  Altogether, these data firmly
establish the role of Nodal/Xnr signaling in the dose-dependent formation of
mesendoderm in vertebrate embryos.
Nodal signaling in left-right axis formation
     Vertebrates exhibit a stereotypical and conserved left-right asymmetry in, for
example, the differential lobation of the lungs, the placement of visceral organs
and the morphogenesis of the cardiovascular system (Wright, 2001; Hamada et
15
al., 2002).  In zebrafish, anatomical asymmetries have been identified in the
forebrain region, such as the diencephalon and parapineal gland (Gamse et al.,
2003; Long et al., 2003).  Deviations from the normal asymmetric placement of
the internal organs, which is referred to as situs solitus, can lead to
randomization of organ placement (heterotaxia) or complete reversal of organ
symmetry (situs inversus).  Although situs inversus is not harmful, heterotaxia
can have severe medical consequences, such as cardiovascular connection
abnormalities and atrial and ventricular septal defects.  (Ramsdell, 2005).  Such
congenital heart defects occur in approximately 90% of individuals exhibiting
heterotaxic phenotypes (Ramsdell et al., 2006).
     Initially, vertebrate embryos are bilaterally symmetric but various species-
specific mechanisms have been discovered that break this embryonic symmetry
(Raya and Belmonte, 2006).  As a result of early breaking of embryonic
symmetry, at around tailbud stage (the equivalent of 2-3 somites in mouse), there
is a transient expression of a “left-side gene cassette” (nodal, lefty and Pitx2) in
the left lateral plate mesoderm (LPM).  This conserved feature is likely a central
event leading to asymmetric morphogenesis (Lowe et al., 1996; Wright, 2001).
During neurula stage in Xenopus, the expression of Xnr1 is observed as
bilaterally symmetrical domains flanking the posterior notochord (Lowe et al.,
1996).  By a mechanism that is not at all well understood, Xnr1 expression then
becomes activated asymmetrically with higher levels on the left LPM and an
extremely low level on the right side (Nakamura et al., 2006).  Recent work in the
Wright lab has demonstrated that planar tissue communication is required for a
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rapid posterior-to-anterior (P-to-A) expansion of the Xnr1 expression domain.
Subsequently, Xnr1 expression becomes rapidly suppressed in a P-to-A manner
(Ohi and Wright, 2007).  In the left LPM, the expression domain of Xenopus lefty
(Xlefty) spatially mirrors that of Xnr1 but with a temporal delay in accordance with
its activation as a direct target of Nodal signaling (Ohi and Wright, 2007).
     As described in detail below, Xlefty inhibits Xnr signaling in both
mesendoderm induction and during L-R axis formation.  In Chapter III, I will
provide evidence that Xlefty undergoes N-linked glycosylation.  Nevertheless, my
assays showed that glycan addition did not influence either the ability of Xlefty to
regulate Xnr signaling during mesoderm induction or the movement of Xlefty
through embryonic tissues of blastula-stage embryos.  Since carbohydrates are a
source of negative charges and may interact with basic domains on extracellular
proteins (Janosi et al., 1999), it is a possible that glycans can influence the speed
of movement of Xlefty during stages of L-R axis formation in Xenopus.  If
“molecular highways” (described above) exist in the left LPM of Xenopus
embryos, there is a possibility that N-linked glycans may affect the path that
Xlefty travels within the embryo.
Negative feedback regulation of Nodal signaling by Lefty
     Lefty-related proteins have been identified in chordates ranging from the very
primitive Ciona to higher vertebrates like mouse and human.  Although several
biological functions have been proposed for Xlefty (Chapter IV), the general
consensus is that a principal activity of Lefty is to antagonize Nodal signaling.
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Lefty molecules are thought to limit the strength, range of signaling, and duration
of Nodal signaling during mesendoderm induction, thereby ensuring the
formation of the proper amount and type of mesendoderm within the embryo
(Branford and Yost, 2002; Chen and Schier, 2002; Feldman et al., 2002; Cha et
al., 2006).  The importance of Lefty molecules in regulating Nodal signaling has
been demonstrated by loss-of-function and gain-of-function experiments in mice,
zebrafish, and frogs.  For example, mice deficient for lefty2 resulted in expansion
of the primitive streak and excess formation of mesoderm (Meno et al., 1999).
This phenotype can be partially rescued by reducing the gene dosage of nodal,
consistent with the idea that overproduction of mesoderm in lefty2 mutants
resulted from increased Nodal signaling (Meno et al., 1999).  Experiments
performed by overexpressing Lefty proteins in zebrafish produced a phenotype
that closely resembled cyc;sqt double mutants or maternal-zygotic oep mutants,
a mutation in the Nodal pathway-required EGF-CFC co-factor (Meno et al.,
1999).  Xenopus Lefty was isolated by Abby Cheng, a former graduate student in
the Wright laboratory, who showed that Xlefty overexpression suppressed Xnr
signaling in mesoderm induction experiments (Cheng et al., 2000).
Subsequently, Young Cha, another former lab member, demonstrated the
importance of Lefty by morpholino-mediated knockdown of the Xlefty protein.
These embryos showed massive expansion in the expression of Xnr-regulated
genes.  For example, Xbra expression in morphant gastrula stage embryos often
encompassed the entire animal hemisphere (Cha et al., 2006).
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     Initially, Lefty-related proteins were thought to inhibit Nodal signaling at the
level of membrane-bound Activin type II receptors (ActRII), as overexpression of
membrane-bound ActRIIA, as well as the extracellular domain of ActRIIB,
suppressed the antagonistic effects of Lefty (Meno et al., 1999; Thisse and
Thisse, 1999).  Subsequent studies, however, suggested a different mechanism
of inhibition.  Using biochemical extracts prepared from Xenopus embryos, and
cultured cells that overexpressed various components of the Nodal signaling
pathway, there are now data supporting the hypothesis that Lefty antagonizes
Nodal signaling by binding either the EGF-CFC cofactor or the Nodal ligand
dimer, thereby blocking the Nodal-receptor interaction (Chen and Shen, 2004;
Cheng et al., 2004; Tanegashima et al., 2004).
Structure of Lefty-related proteins
     Lefty-related proteins are a highly divergent subclass within the TGF
superfamily (Meno et al., 1996; Thisse and Thisse, 1999; Cheng et al., 2000).
Compared to canonical TGF members, Lefty molecules have several unique
structural features (Fig. 1.2).  First, most TGF proteins contain a single
proteolytic cleavage site in the proprotein, which generates a mature domain that
is 110-140 amino acid residues (Kingsley, 1994).  Lefty molecules contain two
cleavage sites (CS1 and CS2), such that proteolytic cleavage of the proprotein
could generate cleaved ligand-like domains of either 220 or 290 amino acids
(Thisse and Thisse, 1999; Cheng et al., 2000; Sakuma et al., 2002).  Second, the
carboxy terminus of most TGF-related ligands is CX1CX1 while that in Lefty-
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related proteins are extended to CX1CX8-13.  Third, Lefty molecules lack the large
-helix and the fourth cysteine residue, both of which are involved in ligand
dimerization.  Thus, Lefty molecules are thought to function as monomers.
Indeed, when secreted from Xenopus animal caps, mouse Lefty 1 and Lefty 2
have so far been detected biochemically as monomers, consistent with these
structural predictions (Sakuma et al., 2002).
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Figure 1.2 Structure of the Xlefty pre-proprotein.  Xlefty is synthesized as a
large pre-proprotein, which can undergo several post-translational modifications
during its maturation.  The signal sequence (SS) targets the proprotein to the
secretory pathway.  There are two potential cleavage sites (CS1 and CS2) in the
proprotein that would be expected to generate long and short isoforms
depending on cleavage site usage.  The one N-linked glycosylation motif ( ) is
present in both long and short isoforms.  The mature domain is missing the
cysteine that is involved in dimerization. C, cysteine; R, arginine; X, any amino
acid
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     All TGF-related proproteins undergo proteolytic cleavage in order to
generate the active ligand (Kingsley, 1994; Nakayama, 1997; Cui et al., 1998;
Constam and Robertson, 1999; Molloy et al., 1999; Ulloa et al., 2001; Beck et al.,
2002; Sakuma et al., 2002; Ben-Haim et al., 2006).  As stated above, proteolytic
cleavage at CS1 and CS2 would be expected to generate long (XleftyL) and short
(XleftyS) isoforms depending upon the cleavage site used.  Such differential
cleavage has of Lefty has been detected in transfected overexpressing cultured
cell lines (Meno et al., 1996).  When mouse Lefty 1 was secreted from 293T and
BALB/3T3 cell lines, proteolytic processing at CS1 and CS2 occurred in a cell
type-dependent manner (Sakuma et al., 2002).  The reason for differential
cleavage of Lefty is not yet understood, but this issue is returned to in Chapter
IV.  Lefty molecules contain a single consensus site for N-linked glycosylation in
the mature domain, and in Chapter III, I present my studies on the
characterization and functional evaluation of N-linked glycosylation and
proprotein cleavage in Xenopus tissues.
     The prevalent idea used to be that TGF molecules were cleaved at a single
SPC motif within the proprotein to allow the release of the ligand for receptor
engagement.  Recently, however, several reports have suggested that a second
cleavage event could influence the biological activity of these secreted
molecules.  I will describe some of the experimental findings illustrating that
cleavage at a second site in the prodomain increases the signaling activity of
BMP-4.  The idea of using different cleavage sites to regulate the activity of a
TGF molecule is important because Lefty molecules contain two cleavage sites
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that could regulate protein turnover or Nodal-blocking function (discussed in
Chapter IV).  As a prototypical member of the TGF superfamily, BMP-4 is fully
expected to require proprotein cleavage to release the active ligand for
productive engagement with receptors.  In vitro assays demonstrated that
Xenopus BMP-4 can be processed by SPC1 (Furin), SPC4, SPC6, and SPC7
(Cui et al., 1998).  In these in vitro BMP-4 cleavage assays, Jan Christian and
colleagues noticed cleavage occurring at an unexpected site in the BMP-4
prodomain (Cui et al., 1998).  From a subsequent series of experiments, they
determined that BMP-4 experienced an ordered cleavage event that influenced
both the strength and range of signaling in Xenopus tissues (Cui et al., 2001).
The first cleavage occurs at the optimal SPC1/Furin site (Site 1; S1) in the
proprotein, which separates the ligand from the prodomain.  The second
cleavage event takes place at a minimal furin site (Site 2; S2) in the prodomain.
Cleavage at S2 is thought to disrupt the non-covalent ligand/prodomain
interaction, and the ligand is released for productive receptor binding.  By
generating an S2 cleavage site mutant, it was determined that preventing
cleavage at S2 caused a marked decrease in the secretion of the mature ligand
domain (Cui et al., 2001).  The decrease in secretion was discovered to be the
result of targeting the ligand domain within the producing cells for rapid
degradation via the lysosomal/proteosomal pathways (Degnin et al., 2004).
Based on the above data, Degnin et al. (2004) suggested that the basal level of
BMP signaling is caused by cleavage of BMP-4 at S1 and tissues that required
higher levels of signaling cleaved BMP-4 at S2.  This hypothesis was supported
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by analyzing mice carrying a targeted mutation that prevented cleavage at S2,
which led to defects being detected in tissues that required the highest level of
BMP signaling (Goldman et al., 2006).
Nodal and Lefty constitute a reaction-diffusion system
     The appropriate level of Nodal signaling is a central determination of proper
pattern formation during mesendoderm formation and L-R axis specification.
Currently, Lefty is thought to act over a long distance to inhibit Nodal signaling.
For example, experiments utilizing both zebrafish and Xenopus showed that
localized injections of lefty RNA into the animal hemisphere could suppress
Nodal signaling many cell diameters away, at the marginal zone (Branford and
Yost, 2002; Chen and Schier, 2002).  It has also been demonstrated that green
fluorescent protein (GFP)-tagged mouse Lefty 2, when electroporated into
chicken embryos, was able to travel further away from its source cells than was a
similarly introduced mouse Nodal-GFP fusion protein (Sakuma et al., 2002).  It
has been suggested that the relationship between Nodal and Lefty resembles
that of the two hypothetical molecules in the classical “reaction-diffusion system”,
as originally proposed by Turing (1990).  Using a series of mathematical
equations, this model describes the generation of complex tissue patterning
within the embryo as a self-buffering system between a short-range morphogen
and its long-range antagonist.
     There are several principal interactions that are postulated to occur between
the activator and the inhibitor in the reaction-diffusion model.  First, the
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morphogen induces its own production, as well as activating the expression of
the inhibitor.  The antagonist then functions to short-circuit the auto-activation of
the activator.  Finally, the long-range antagonist acts to restrict the range of
short-range positive feedback loop of the activator.  All of the current loss-of-
function and gain-of-function data, including effects on target genes, suggest that
Nodal and the feedback antagonist Lefty interact in such a self-regulating
system.
Aims of the dissertation
     The broad goal of my Ph.D. thesis research project was to examine how post-
translational modifications influence the ability of Xlefty to regulate Nodal
signaling during mesendoderm induction in Xenopus laevis.  Currently, the
published reports characterizing how proprotein cleavage of Lefty affects its
ability to regulate Nodal signaling have come from heterologous experiments,
which could lead to incorrect findings.  In these experiments, mouse Lefty and
the various cleavage mutants were co-expressed with Nodal and a Nodal-
regulated luciferase reporter plasmid in Xenopus animal caps.  Therefore, my
studies were carefully designed to analyze proteolytic cleavage of Xlefty in the
homologous tissue context of Xenopus and at the appropriate developmental
time.  In Chapter III of this dissertation, I describe biochemical and embryological
assays that demonstrate the role of post-translational modifications in regulating
Nodal signaling.  Some major conclusions from my studies are that Xlefty
undergoes both proteolytic cleavage and N-linked glycosylation.  Proprotein
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cleavage of Xlefty is required to inhibit Nodal signaling while glycosylation does
not inhibit Xnr signaling in mesoderm induction assays and does not alter the
movement of Xlefty through embryonic tissues.  Because the proteolytic
cleavage characteristics of Xlefty occurred at CS1 and CS2 when secreted from
oocytes but cleavage only happened at CS1 when embryonic tissues were
assayed, a major conclusion is that future experiments should utilize embryonic
cells to investigate the mechanisms that regulate the biochemical processing of
secreted proteins.  In chapter IV, I present a synopsis on the significance of my
findings and the direction of future experiments.
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CHAPTER II
MATERIALS AND METHODS
Embryo manipulations
     Embryos were obtained by in vitro fertilization of eggs from hormonally
induced Xenopus laevis females (Kay and Peng, 1991).  Embryos were dejellied
in 1% thioglycolic acid in 1X Steinberg solution (1X SS; 4.6 mM Tris-HCl pH 7.4,
58 mM NaCl, 0.67 mM KCl, 0.34 mM Ca(NO3)2, 0.83 mM MgSO4) and
subsequently cultured in 1X SS.  Embryos were staged according to Nieuwkoop
and Faber (1967).
Embryo injections
     Fertilized embryos were transferred to 5% Ficoll/1X SS and injected using a
Narashige gas driven microinjector.  Depending on the blastomere size, the
injection volume ranged from 1 nl to 10 nl (10 nl for the one-cell stage, 2.5 nl for
the 4-cell stage, and 1 nl for the 32-cell stage).  Injected embryos were allowed to
recover at room temperature in 5% Ficoll/1X SS until stage 9 and then
transferred to 0.1X SS for the remainder of the culture period.
     Capped RNAs were synthesized using SP6 mMessage mMachine (Ambion)
from the following linearized plasmids: CS2+Xnr2 (Jones et al., 1995);
CS2+Xlefty (Cheng et al., 2000); CS2+Zebrafish Lefty1 (Thisse and Thisse,
1999); SP64TL-Mouse Lefty1, pSP64TL-Mouse Lefty2; (Sakuma et al., 2002);
27
CS2+Xnr5 (Takahashi et al., 2000); CS2+nLacZ.  The following plasmids
(generated for the studies performed in this thesis; for detail see below) were
linearized to make synthetic RNA: CS2+Xnr2NGM; CS2+Xnr5G; CS2+Xleftymcs1;
CS2+Xleftymcs2; CS2+Xleftymcs1/2; CS2+Xleftymcs1myc; CS2+Xleftymcs2myc;
CS2+Xleftymcs1/2myc; CS2+XleftyHA; CS2+XleftyNGM-A; CS2+XleftyNGM-S;
CS2+Xleftymyc; CS2+XleftyNGM-Amyc.
Xenopus oocyte isolation and injection
     Xenopus oocytes were isolated and defolliculated according to Sive et al.
(2000).  Oocytes were cultured in O-R2 (pH 7.8: 82.5 mM NaCl, 2.5 mM KCl, 1
mM CaCl2, 1 mM MgCl2, 1 mM Na2HPO4, and 5 mM HEPES) supplemented with
0.5 mg/ml bovine serum albumin (BSA), 100 units/ml penicillin (Specialty Media),
and 100 µg/ml streptomycin (Specialty Media).  For protein expression, a 10 nl
volume was used to inject 30-50 ng of synthetic RNA per oocyte.  After injection,
the oocytes were allowed to recover for three hours at room temperature in O-
R2/BSA/penicillin/streptomycin described above.  Subsequently, five oocytes
were transferred to a single well (prerinsed with O-R2 plus 15 mg/ml BSA) in a
96-well plate containing 50 µl of Labeling Medium.  Labeling Medium consisted of
250 µCi [35S]methionine and [35S]cysteine (Promix; >1000mCi/mmol; GE
Healthcare catalogue # AGQ0080) dissolved in O-R2/BSA/penicillin/streptomycin
described above.  A 10 mg/ml stock concentration of tunicamycin (Sigma) was
prepared by dissolving in dimethyl sulfoxide (DMSO).  To inhibit N-linked
glycosylation, 10 nl was used to inject of 2 ng of tunicamycin per oocyte and
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followed by culturing in O-R2/BSA/penicillin/streptomycin plus 2 µg/ml
tunicamycin (Colman, 1984).  After tunicamycin injection, oocytes were cultured
with no agitation for 2 hours before RNA injection.  Supernatants were collected
by carefully removing as much conditioned medium as possible (approximately
40 µl) with the P200 pipetmen after overnight incubation at 19ºC.  Samples were
stored at -20ºC for further analysis.  Sample buffer (4X: 40 % glycerol, 0.1M 2-
mercaptoethanol, 25 mM EDTA, 10 % SDS, 0.125 M Tris pH 6.8, 0.05 %
bromophenol blue) was added to 15 µl of conditioned medium, boiled for three
minutes, microcentrifuged for 30 seconds, and resolved using precast 10% Bis-
Tris NuPAGE SDS-PAGE gels (Invitrogen; catalogue # NP0301Box) and
NuPAGE MOPS SDS running buffer (Invitrogen; NP0001)
Protein isolation from whole embryos
     For analysis of proteins secreted from embryonic tissues, embryos were
injected with the indicated RNAs and cultured to stage 10-10.5 in 1 X SS.  Ten
whole embryos were lysed by pipetting up and down in 300 µl of lysis buffer (pH
7.4: 50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.25% sodium
deoxycholate, 1 µM leupeptin, 1 µM pepstatin, 1 mM PMSF).  Lysates were
microcentrifuged at 14,000 rpm at 4ºC for 5 minutes.  Following
microcentrifugation, soluble protein (located between the insoluble protein pellet
and the pellicular layer; approximately 200 µl) was transferred to a new 1.5 ml
tube.  Following the addition of sample buffer (see above), one-half embryo
equivalent of soluble protein was loaded per lane.
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Protein secretion from embryonic tissues
     Animal halves were isolated by cutting along the equator with a surgical knife
to separate the animal hemisphere from the vegetal hemisphere, and animal
caps were isolated using the Gastromaster® dissector with 400 µm size square
loop tips.  After tissue isolation, 12 animal halves or 25 animal caps were
cultured per well in a 96-well plate containing 40 µl of calcium magnesium-free
medium (7.5 mM Tris-HCl pH 7.6; 88 mM NaCl,1 mM KCl, 2.4 mM NaHCO3)
containing 0.1 mg/ml BSA at room temperature (Sives et al., 2000).
Supernatants (approximately 35 µl) were collected with a P200 pipetmen after
three hours for western blot analysis.  
Enzymatic removal of N-linked glycans
     PNGase F (New England Biolabs, catalogue # P0704S) digestion was
performed on conditioned medium secreted from Xenopus oocytes and
embryonic tissues.  Conditioned medium (30 µl from oocytes and 20 µl from
animal halves and animal cap) was performed according to the manufacturer
protocol prior to gel electrophoresis.  Briefly, protein was denatured in 1X
glycoprotein denaturation buffer (0.5% SDS and 2% -mercaptoethanol) for 10
minutes at 100ºC.  Next, the solution was allowed to cool to room temperature.
10X G7 reaction buffer (0.5 M sodium phosphate, pH 7.5) was diluted to a final
concentration of 1X, and 10% NP-40 was diluted to a final concentration of 1%.
Finally, 1 µl of PNGase F (500 units) was added and the reaction was incubated
at 37ºC for 1 hour.
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MAPK assay
     In order to stimulate activation of endogenous MAPK, whole embryos were
wounded by rapidly cutting the embryo into quarters along the animal-vegetal
axis with a surgical knife at stage 9 and cultured for 15 minutes.  Animal caps
were isolated using the Gastromaster® dissector with 400 µm size square loop
tips at stage 9 and cultured for 15, 60, and 120 minutes.  Three whole embryo
equivalents (12 quarters) were lysed by rapidly pipetting up and down with a
P200 pipetmen in 100 µl of lysis buffer (10 mM Tris–HCl pH 7.5, 100 mM NaCl, 5
mM EDTA, 0.5% Nonidet P-40, 1 µM leupeptin, 1 µM pepstatin, 1 mM PMSF, 50
mM NaF, 10 mM Na2P2O7, 0.5 mM Na3VO4) and 15 animal caps were lysed by a
similar pipetting method in 30 µl of lysis buffer.  Lysates from whole or quartered
embryos were microcentrifuged at 14,000 rpm at 4ºC for 5 minutes.  Soluble
protein (located between the pellet and pellicle; approximately 70 µl) was
transferred to a new tube and stored at -20ºC for further analysis.  Sample buffer
was diluted to a final concentration of 1X and boiled for three minutes.  One-half
embryo equivalent of soluble protein was loaded per lane for western blot
analysis.  Sample buffer (10 µl) was added to lysates from animal caps and
microcentrifuged at 14,000 rpm at 4ºC for 5 minutes to pellet insoluble protein.
7.5 animal cap equivalents of soluble protein were loaded per lane.
Western blots
     Embryonic lysates and secreted proteins were resolved using precast 10%
Bis-Tris NuPAGE SDS-PAGE gels and NuPAGE MOPS SDS running buffer
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(described earlier).  Proteins were transferred to Immobilon-P PVDF (Millipore;
catalogue # IPVH00010) and were blocked for 2 hours in 1X Tris-buffered saline
(TBS; 100 mM Tris-HCl pH 7.6 and 150 mM NaCl) containing 5% non-fat dry milk
(NFDM; Kroger brand) and 0.1% Tween 20 (Fisher; catalogue # BP337).
Primary and secondary antibodies were incubated in 1X TBS containing 1%
NFDM and 0.1% Tween 20.  Membranes were washed 4 times in 1X TBS plus
0.1% Tween 20 for 15 minutes after primary and secondary antibody incubation.
    The following antibodies were diluted 1/2000 in 1X TBS containing 1% NFDM
and 0.1% Tween 20: anti-myc (9E10; Vanderbilt University Antibody Core), anti-
HA (12CA5; Vanderbilt University Antibody Core), anti-phospho-p44/42
(phospho-ERK1/2; Cell Signaling Technology catalogue # 9101) and anti-p44/42
(ERK1/2; Cell Signaling Technology catalogue # 9102).  Horseradish peroxidase-
conjugated anti-mouse IgG and anti-rabbit IgG (Santa Cruz Biotechnology
catalogue numbers sc-2314 and sc-2004, respectively) were diluted 1/2000 and
used as secondary antibodies. SuperSignal West Pico Chemiluminescent
Substrate (Pierce) was used to detect Horseradish peroxidase on immunoblots.
In vitro translation and N-linked glycosylation
     Canine Pancreatic Microsomal Membranes (Promega; catalogue # L4610)
were used for in vitro translation and N-linked glycosylation analysis.  Capped
mRNA was synthesized using SP6 mMessage mMachine (Ambion).  250 ng of
Xlefty RNA was used to prime rabbit reticulocyte lysate system.  Promix
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(described above) was used for metabolic labeling.  The reaction was performed
according to manufacturer protocol.
Animal cap assays
     One-cell stage embryos were injected with RNA.  Vitelline membranes were
removed from stage 8.5/9 embryos.  Animal caps were explanted at stage 8.5/9
using the Gastromaster® 400 µm tip and cultured in 1 X SS.  Explanted animal
caps were collected at sibling stage 10.5, and flash frozen in dry ice/ethanol for
RT-PCR analysis.
RT-PCR
     Total RNA from three whole embryos or 25 animal caps was isolated using
TRIzol (Invitrogen) according to manufacturer protocol.  cDNA synthesis was
performed with 2 µg of total RNA using 200 units of SuperScript II (Invitrogen;
catalogue # 15596-018) and 5 nmoles of Oligo d(T)16 (Applied Biosystem).  After
cDNA synthesis, the volume of the reaction was adjusted to 80 µl by adding 60 µl
of distilled water.  Each set of reactions included a control reaction without
reverse transcriptase.  PCR reactions were performed with 4 µl from the cDNA
synthesis reaction and contained 0.75 units of Taq polymerase (Fisher), 0.25 mM
of each dNTP, and 0.2 µM of gene-specific primers.  PCR products were trace-
labeled with 2 µCi of [-32P]-dATP (GE Healthcare catalogue # AA0004,
~3000Ci/mmol) .  After an initial 5 minute denaturation step at 95ºC, the reactions
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cycled for 1 minute at 94ºC, 1.5 minutes at 55ºC and 1 minute at 72ºC.  After 24
to 28 cycles (see Table 2.1 for cycle number), a final extension step was carried
out for 5 minutes at 72ºC.
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Table 2.1 PCR primers and cycle number
Gene
name Sequences
Cycle
number
goosecoid F ACAACTGGAAGCACTGGA 28
R TCTTATTCCAGAGGAACC
chordin F CCTCCAATCCAAGACTCCAGCAG 26
R GGAGGAGGAGGAGCTTTGGGACAAG
noggin F AGTTGCAGATGTGGCTCT 27
R AGTCCAAGAGTCTCAGCA
Xbra F GGATCGTTATCACCTCTG 28
R GTGTAGTCTGTAGCAGCA
odc F GGAGCTGCAAGTTGGAGA 24
R TCAGTTGCCAGTGTGGTC
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Whole-mount immunostaining and Red-Gal staining
     Whole-mount immunostaining was performed using albino embryos.
Embryos were co-injected with Xleftymyc or XleftyNGM-Amyc RNA and a lineage-
tracer RNA that encodes a nuclear-targeted -galactosidase into one marginal
blastomere of a 32-64 cell-stage embryo.  Vitelline membranes were carefully
removed from stage 9 embryos. Embryos were formaldehyde fixed in MEMFA
(0.1 mM MOPS pH 7.4, 2 mM EGTA, 1 mM MgSO4, 3.7 % formaldehyde) for 1
hour, and washed three times in 1X phosphate-buffered saline (PBS).  gal was
detected with Red-Gal (Research Organics; catalogue # 1364C) by incubating at
room temperature in reaction buffer (1X PBS, 5 mM K3Fe(CN)6, 5 mM
K4Fe(CN)6, 2 mM MgCl2, 1 mg/ml Red-Gal; Sive et al., 2000) for approximately
30 minutes.  Next, embryos were washed three times in 1X PBS and post-fixed
in MEMFA for one hour.  Embryos were washed three times in 1X PBS
containing 0.2% Triton-X100 (PBST) and blocked in two solutions for 1 hour
each: (i) PBST containing 2% milk and 2 mg/ml BSA and (ii) PBST contain 10%
donkey serum, 2 % milk, and 2 mg/ml BSA.  Anti-myc antibody (9E10; Vanderbilt
University Antibody Core) was diluted to 1:3000.  Alkaline phosphatase-linked
anti-mouse secondary antibody (Jackson ImmunoResearch, catalogue # 715-
055-151) was reconstituted in 500 µl of sterile water.  500 µl of glycerol was
added for a final concentration of 50% glycerol.   The secondary antibody was
then diluted to 1:1500.  Primary and secondary antibodies were diluted in
blocking buffer containing 10% donkey serum and incubated overnight at 4ºC.
Embryos were washed 10 times in PBST for 30 minutes after primary and
36
secondary antibody incubation. BM purple (Roche; catalogue # 11442074001)
signal was terminated after approximately 30 minutes.  In comparative
experiment, all parallel-processed samples were stopped at the same time.
     For bisection, embryos were collected 1, 2, 3, and 4 hours post-injection.
Embryos were MEMFA-fixed for one hour at room temperature and washed three
times in 1X PBS.  Red-Gal staining and MEMFA post-fix were performed as
described above.  Embryos were equilibrated in 0.3 M sucrose in 1X PBS for 5
minutes and then embedded in 1X PBS/0.3 M sucrose/2% low melting point
agarose.  Embryos were bisected through the patch of Red-Gal marked clone.
The bisected embryos were removed from the agarose, washed for 5 minutes in
1X PBS/0.3 M sucrose and then washed three times for 5 minutes in 1X PBST.
Antibody incubations and washes were performed as described above.
DNA constructs
XleftyHA
     The QuickChange Site-Directed Mutagenesis Kit (Stratagene; catalogue #
200519) was used to add a NheI site 4 amino acids downstream of cleavage site
2 with the following primers: Nhe-Xlefty-top 5-
CACCGACCTGTCAACAATGGAGCTAGCGGAGCCAGAGTTAGTGTGTAT-3;
Nhe-Xlefty-bottom 5-
ATACACACTAACTCTGGCTCCGCTAGCTCCATTGTTGACAGGTCGGTG-3
(NheI site underlined).  The following oligonucleotides were annealed and
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inserted into NheI digested CS2+XleftyNheI: 5-
CTAGCGGATATCCATATGATGTGCCAGATTATGCAGGATATCCATATGATGT
GCCAGATTATGCAGGAG-3; 5-
CTAGCTCCTGCATAATCTGGCACATCATATGGATATCCTGCATAATCTGGCA
CATCATATGGATATCCG (HA epitope tag underlined).
XleftyNGM-A and XleftyNGM-S
     The QuickChange Site-Directed Mutagenesis Kit (Stratagene) was used to
mutate the N-linked glycosylation site “NRT” (asparagine arginine threonine) to
either “ART” (NGM-A; alanine arginine threonine) or “SRT” (NGM-S; serine
arginine threonine) with the following primers: NGM-A-Top 5-
TTGAAAGATGGCACCGCCAGAACCTCCCTGGTG-3; NGM-A-Bottom 5-
CACCAGGGAGGTTCTGGCGGTGCCATCTTTCAA-3; NGM-S-Top 5-
TTGAAAGATGGCACCAGCAGAACCTCCCTGGTG-3; NGM-S-Bottom 5-
CACCAGGGAGGTTCTGCTGGTGCCATCTTTCAA-3 (mutated N-linked
glycosylation underlined).
Xleftymcs1, Xleftymcs2, and Xleftymcs1/2
     The QuickChange Site-Directed Mutagenesis Kit (Stratagene) was used to
mutate cleavage sites (CS1 and/or CS2) from “R-X-X-R” to “G-V-D-G” with the
following primers: CS1-Top 5-
ATGCTGCACAATCACAGAGAGGGGGTGGATGGATCACTGCCCAGCTTGGC
TGGC-3; CS1-Bottom 5-
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GCCAGCCAAGCTGGGCAGTGATCCATCCACCCCCTCTCTGTGATTGTGCAG
CAT-3; CS2-Top 5-
ATCATGAACGTTCCAGAAAGGGGAGTCGACGGACCTGTCAACAATGCCAGA
GTT-3; CS2-Bottom 5-
AACTCTGGCATTGTTGACAGGTCCGTCGACTCCCCTTTCTGGAACGTTCATG
AT-3 (mutated cleavage site underlined).
Xleftymyc, XleftyNGMmyc, Xleftymcs1myc, Xleftymcs2myc and Xleftymcs1/2myc
     The open reading frame of Xlefty, XleftyNGM and the various cleavage mutants
were PCR amplified with the following primers: Xlefty-5-myc 5-
CGCGGATCCATGGGTGTCACTACCAAATCTTTG-3; Xlefty-3-myc 5-
CGCGGATCCTATGATAGCGATATTGTCCATTGT-3.  The PCR product was
digested with BamHI and subcloned into CS2+MT digested with BamHI.
Xnr2NGM
     The QuickChange Site-Directed Mutagenesis Kit (Stratagene) was used to
mutate the N-linked glycosylation site “NET” to “AET” (NGM) with the following
primers: Xnr2-NGM-5 5-
GCCTGTCCTATTCCTTTAGCTGAAACCTTCAAGCCAACG-3; XNR2-NGM-3
5-CGTTGGCTTGAAGGTTTCAGCTAAAGGAATAGGACAGGC-3 (mutated
glycosylation site underlined).
Xnr5G
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     The QuickChange Site-Directed Mutagenesis Kit (Stratagene) was used to
add N-linked glycosylation site “NGT” with the following primers: Xnr5-N-5 5-
TGCCCGATTCCACTGAATGAGACCTTCAAGCCAACAAA-3; Xnr5-N-3 5-
GTTTGTTGGCTTGAAGGTCTCATTCAGAGGAATCGGGCA-3 (N-linked
glycosylation motif underlined).
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CHAPTER III
THE EFFECT OF POST-TRANSLATIONAL MODIFICATIONS ON XLEFTY
FUNCTION
Introduction
     During metazoan embryogenesis, intercellular signaling molecules in the
hedgehog, Wnt and TGF families are used reiteratively and in combination to
initiate various developmental programs (Freeman and Gurdon, 2002; Tabata
and Takei, 2004).  Especially in early embryogenesis, the regulated transcription
of the genes encoding these signaling molecules, as well as the level of activity
of their extracellular antagonists, and other factors, are involved in the generation
of morphogen activity gradients that lead to the spatially ordered specification of
cell fates.  There are several mechanisms that assist in shaping morphogen
gradients.  A good example of the effect of post-translational modification is seen
in the addition of cholesterol to proteins in the Hedgehog family, which regulate
the range of spreading of this factor through tissue in several systems (Li et al.,
2006; Su et al., 2007).  For FGF8, the rate of clearing via endocytosis controls
the amount of extracellular protein available for signaling as well as the distance
the protein is able to travel from the source of production (Scholpp and Brand,
2004). It is easy to imagine how receptor availability and extracellular antagonists
are powerful dynamic regulators of morphogen gradients (Smith and Harland,
1992; Sasai et al., 1994; Bouwmeester et al., 1996; Goodrich et al., 1996; Meno
et al., 1996; Meno et al., 1999; Thisse and Thisse, 1999; Cheng et al., 2000;
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Tanegashima et al., 2000; Larrain et al., 2001; Branford and Yost, 2002; Chang
et al., 2003; Harms and Chang, 2003; Zhang et al., 2004).  The preferential
intracellular degradation of mRNA for a signaling molecule gene can contribute to
formation of a morphogen gradient.  For example, progressive clearance of fgf8
mRNA is translated into a gradient of FGF8 protein that appears to be required
for proper axis elongation during vertebrate embryogenesis (Dubrulle and
Pourquie, 2004).
     The Nodal ligand binds a receptor complex that includes Activin type 1 and
type 2 receptors (Whitman, 2001), together with an EGF-CFC family co-receptor
(Shen et al., 1997; Ding et al., 1998; Zhang et al., 1998; Dorey and Hill, 2006;
Onuma et al., 2006).  Lefty, a divergent member of the TGF family whose
transcription is directly regulated by Nodal signaling, is one of the principal
extracellular feedback inhibitors of Nodal signaling (Meno et al., 1996; Meno et
al., 1999; Thisse and Thisse, 1999; Cheng et al., 2000; Tanegashima et al.,
2000; Branford and Yost, 2002; Cha et al., 2006).  The current understanding is
that Lefty antagonizes Nodal signaling by binding to either the EGF-CFC cofactor
directly, or by physically interacting with the Nodal ligand, thereby blocking
Nodal-receptor interaction and inhibiting downstream signal transduction (Chen
and Shen, 2004; Cheng et al., 2004; Tanegashima et al., 2004).
     Calcium-dependent serine endoproteases of the subtilisin-like proprotein
convertase family (SPCs) recognize the consensus R-X-X-R motif found in many
intercellular signaling molecule proproteins, including Nodal and Lefty
(Nakayama, 1997; Molloy et al., 1999).  SPCs, of which there are seven distinct
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mammalian family members, have been localized to the intracellular secretory
network as well as having been detected in association with the extracellular
matrix.  SPC-mediated cleavage releases the active ligand during the maturation
of TGF proteins (Kingsley, 1994; Nakayama, 1997; Cui et al., 1998; Constam
and Robertson, 1999; Molloy et al., 1999; Ulloa et al., 2001; Beck et al., 2002;
Sakuma et al., 2002; Ben-Haim et al., 2006).  In principle, therefore, SPCs may
work in both a cell-autonomous (i.e., within the proprotein producing cell) and
non-cell-autonomous manner from adjacent cells (Nakayama, 1997; Molloy et al.,
1999).  Although mammalian Lefty molecules have been shown to undergo
proteolytic cleavage by SPC1, SPC4, and SPC6 in several transfected cultured
cell lines, the endogenous SPC enzyme(s) that is involved in the proteolytic
processing of Lefty in vivo is currently not known (Ulloa et al., 2001; Beck et al.,
2002; Sakuma et al., 2002).
     There is much evidence that cleavage mutants (which cannot undergo
proprotein processing) of various TGF molecules are either not secreted or are
biologically inactive (Lopez et al., 1992; Hawley et al., 1995; Osada and Wright,
1999; Sun et al., 1999; Yeo and Whitman, 2001; Eimon and Harland, 2002;
Onuma et al., 2002; Sakuma et al., 2002; Onuma et al., 2005).  Recently,
however, several reports have suggested that uncleaved proproteins retain some
signaling function.  In one example, Eimon and Harland (2002) demonstrated
that overexpressed cleavage-resistant Xnr2 was capable of inducing the
expression of mesodermal genes in Xenopus embryos, although this activity was
weaker than normal protein, and has so far not been detected by other groups
43
(Osada and Wright, 1999; Onuma et al., 2002; Hashimoto-Partyka et al., 2003;
Onuma et al., 2005).  The reason for this discrepancy remains unclear.  A similar
activity was reported for a non-cleavable form of mouse Nodal, and in this case,
the proprotein has been suggested to be able to bind and signal through Activin
receptors to induce significant expression of BMP4, furin/spc1 and spc4 (Ben-
Haim et al., 2006).  Yet another report demonstrated that affinity purified human
Lefty A proprotein could activate the MAP kinase pathway in P19 mouse
embryonic carcinoma cells when added to the culture medium (Ulloa et al.,
2001).
     The Xenopus Lefty proprotein has two potential cleavage sites that would be
expected to produce a long (XleftyL) or short (XleftyS) isoform by cleavage at site
1 (CS1) or site 2 (CS2), respectively.  When tested in 293T and BALB/3T3 cell
lines, CS1 and CS2 cleavage of mouse Lefty 1 seemed to depend on the cell
type (Meno et al., 1996).  Expression of mouse Lefty 1 and Lefty 2 in Xenopus
tissues (animal caps and oocytes) and COS-7 cells resulted in the detection of
the short isoform for Lefty 1 and the long isoform for Lefty 2 (Sakuma et al.,
2002).
     Several TGF family members contain at least one N-linked glycosylation
consensus sequence in the proprotein that may affect the secretion, protein
stability and biological function of the ligand domain.  Specifically, TGF1 and
TGF2 require the addition of N-linked glycans at three sites in the prodomain for
efficient secretion of the ligand into the culture medium (Brunner et al., 1992;
Lopez et al., 1992).  In another example, the modification of mouse Nodal by
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inserting an N-linked glycosylation motif that is found in five of the six Xenopus
Nodal-related factors and absent from mouse Nodal led to a greatly increased
ligand stability (Le Good et al., 2005).  The presence in Lefty molecules of a
single N-linked glycosylation motif in the mature region that might influence
intrinsic protein stability or Nodal-blocking function is an issue that we address in
this thesis.
     As stated above, Sakuma et al. (2002) and Ulloa et al. (2001) assayed the
cleavage of mammalian Lefty in Xenopus tissues or in several mammalian
cultured cell lines, which may not be the appropriate tissue context to study the
processing of this important intercellular antagonist, especially when considering
how its activity in specifying the patterning of embryonic tissue.  Therefore, we
decided to examine the single Xenopus Lefty molecule in a homologous tissue
context within the developing Xenopus embryo, and during a period when Xlefty
is normally expressed.  We report here on our assays of how proprotein
processing and N-linked glycosylation affected protein stability, biological
function and movement through embryonic tissues.  We found that Xlefty
undergoes cleavage at CS1 and CS2 when secreted from Xenopus oocytes, but
that only XleftyL is detected when produced from embryonic tissues.  The use of
cleavage mutants to direct the production of either the long or short isoform
showed in a mesoderm induction assay context that XleftyL is the inhibitory
isoform.  Additionally, this is the first report that demonstrates that vertebrate
Lefty molecules are secreted as glycosylated proteins, but our assays suggest
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that glycosylation does not alter the gross biological function or the movement of
Xlefty through blastula stage embryonic tissue.
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Results
Lefty molecules are secreted as glycoproteins
     Lefty molecules contain a single N-linked glycosylation consensus sequence
in the mature domain that could affect intrinsic protein stability or post-secretion
clearance, its biological effectiveness as a Nodal antagonist, and/or the range of
movement through embryonic tissue.  To determine if core glycosylation of the
proprotein could occur, in vitro translation of Xlefty RNA was performed in the
presence and absence of canine pancreatic microsomal membranes.  When
Xlefty was used as a template in the absence of microsomal membranes, a
signal band of approximately 38 kDa was produced (Fig. 3.1).  When the reaction
was carried out in the presence of microsomal membranes, two bands were
detected.  The lower band had a migration equivalent to that of Xlefty produced
in the absence of microsomal membranes, while the slower migrating and distinct
appearance of the second band indicated post-translational modification, likely
glycosylation (Fig. 3.1).
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Figure 3.1 Post-translational modification of Xlefty.  TNT reaction primed with
250 pg of Xlefty RNA in the absence (-) and (+) presence of canine pancreatic
microsomal membranes.
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     In order to determine if the glycosylation motif is functional in vivo, RNAs
encoding Xenopus Lefty, zebrafish Lefty 1, mouse Lefty 1 and mouse Lefty 2
were injected into Xenopus oocytes and the resulting conditioned medium was
analyzed by SDS-PAGE.  Radiolabeled Lefty molecules detected in the
conditioned medium migrated slower than predicted and as diffuse bands, a
typical behavior of glycoproteins (Fig. 3.2A).  When tunicamycin was injected into
the oocytes prior to the RNA, the secreted proteins migrated faster and as
sharper bands.  The presence of glycosylation was confirmed by treating the
Lefty-containing media samples with a deglycosylase, PNGase F, prior to gel
electrophoresis (Fig. 3.2A).  These data demonstrated that vertebrate Lefty
molecules were glycosylated when secreted from Xenopus oocytes.  The
tunicamycin result showed that, unlike TGF1 and TGF2, Lefty molecules do
not require the presence of N-linked glycans for efficient secretion into the
medium.
     Mouse Lefty 2 contains two potential cleavage sites, with cleavage reported to
occur only at CS1 in Xenopus animal caps and COS-7 cells.  Furthermore, I the
same studies, animal cap expression of mouse Lefty 2 carrying a mutant CS1
resulted in the detection of only the proprotein, suggesting that CS2 is strongly
refractory to cleavage (Sakuma et al., 2002).  We wanted to determine if both
CS1 and CS2 were utilized for proteolytic processing of the Xlefty proprotein.
Injection of Xlefty RNA into Xenopus oocytes resulted in equal amounts of both
long and short isoforms (XleftyL and XleftyS, respectively) in the conditioned
medium (Fig. 3.2).
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Figure 3.2  Glycosylation of Lefty molecules.  A, B: Medium was analyzed
from Xenopus oocytes injected with the indicated RNAs, metabolically labeled
with [35S]-methionine/cysteine.  Black dots, major glycosylated and
deglycosylated bands. Un, uninjected oocytes; V, vehicle (1% DMSO); (-),
oocytes not injected with tunicamycin, or conditioned medium not treated with
PNGase F; T, tunicamycin; P, PNGase F.
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This finding suggested that cleavage occurred at CS1 and CS2 with equal
efficiency for wild-type Xlefty.  To test for the cleavage efficiency at each CS, we
used site-directed mutagenesis to disrupt the protease recognition site at one or
both cleavage sites.  Injection of Xleftymcs1 RNA (mutant cleavage site 1;
encoding an uncleavable CS1) resulted in detection of XleftyS and the proprotein,
together with minor amounts of unknown and perhaps spurious cleavage
products.  Although only a functional CS2 was available in this proprotein, the
presence of substantial proprotein in the conditioned medium indicated that CS2
cleavage was inefficient.  This result can be interpreted as suggesting that
cleavage at CS1 is required for further processing at CS2, a situation similar to
that noted for BMP-4, as described in more detail in the Discussion (Cui et al.,
2001).  Conversely, injection of Xleftymcs2 RNA (in which only CS1 is functional)
resulted in detection of XleftyL without appreciable proprotein, suggesting that
CS1 cleavage was extremely efficient (Figure 3.2B).  Injection of double-
cleavage-site-mutant Xleftymcs1/2 RNA resulted in secretion of the proprotein and
a small proportian of unknown cleavage products (Figure 3.2B).  Proprotein
cleavage is therefore not required for Xlefty secretion, which differs from reports
showing that cleavage is required for secretion of TGF1 and Derrière (Lopez et
al., 1992; Eimon and Harland, 2002).
     The initial steps of N-linked glycosylation occur in the endoplasmic reticulum
with further maturation in the Golgi complex (Helenius and Aebi, 2001).  SPC1,
SPC4, and SPC6 have been localized to the trans-Golgi network and secretory
granules, as well as at the cell surface and secreted to the extracellular matrix
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(Molloy et al., 1999; Bergeron et al., 2000; Beck et al., 2002; Tsuji et al., 2003;
Nour et al., 2005).  Although the effect of N-glycosylation has not yet been
directly assessed on the structure of TGF family proteins, experiments with
synthetic peptides have demonstrated that N-linked glycans can induce a
compact -turn in the vicinity of the carbohydrate addition (O'Conner and
Imperiali, 1998; Helenius and Aebi, 2001).  Therefore, there is a possibility that
the presence or absence of N-linked glycans could generate a protein
conformation that is unsuitable for SPC-mediated cleavage.  In order to test if
glycosylation affected cleavage at CS1 and CS2, tunicamycin was injected into
the oocytes prior to the RNAs encoding the various cleavage mutants.  Although
the secreted proteins migrate at different rates, the similarity of the cleavage
patterns generated from the various cleavage mutant proteins in the presence or
absence of tunicamycin suggests that glycosylation does not alter CS1/CS2
cleavage characteristics (Figure 3.2B).  Again, PNGase F treatments confirmed
the presence of glycosylation.  In addition, the similarity of migration of the
cleavage products detected in the presence of tunicamycin or with PNGase F
treatment suggested that the previous tunicamycin treatment blocked the
majority of N-linked glycan addition.
     We next examined the cleavage and glycosylation characteristics of Xlefty
secreted from embryonic tissues.  We analyzed conditioned media from the
dissociated cells from entire animal halves (the animal hemisphere cut away at
the equator) or standard animal caps.  Since there are no Xlefty antibodies
available to detect either the endogenous (which is in any case likely expressed
52
at difficult-to-detect low levels) or overexpressed normal protein, an HA epitope-
tagged version was utilized for these experiments.  When overexpressed in
whole embryos, XleftyHA (containing a tag placed 4 aa after CS2; see Chapter II)
induced an embryonic phenotype similar to that caused by wild-type Xlefty at
equivalent RNA doses (not shown), and the HA tag did not interfere with
secretion or stability of Xlefty (not shown), demonstrating that HA tagging at this
location did not affect its biological function.  When expressed in Xenopus
embryonic tissues, XleftyHA was secreted as a glycosylated protein, as confirmed
by PNGase F treatment  (Figure 3.3) and only XleftyL was detected.  In similar
experiments with myc-tagged versions of Xlefty or the various cleavage mutants,
XleftyL and the proprotein were detected in cell extracts from whole embryos, or
in the conditioned media from dissociated animal halves (Fig. 3.4).  Similar to
data gathered from oocyte secretion assays, the proprotein was efficiently
secreted from animal halves (Fig. 3.4B).  These results indicate that Xlefty is
glycosylated in embryonic tissues, and that XleftyL is the only isoform of the
protein that accumulates to detectable levels either in homogenized whole
embryos extracts, or secreted from embryonic cells.
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Figure 3.3 Secreted Xlefty is a glycoprotein. A,B: Western blot of conditioned
medium from dissociated animal halves (A) and animal caps (B) isolated from
embryos injected at the one-cell stage with 2.5 ng of XleftyHA RNA.  Un,
uninjected embryos; (-), conditioned medium not treated with PNGase F; P,
PNGase F; L, XleftyL (filled arrowhead); S, XleftyS (open arrowhead).
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Figure 3.4  XleftyS not detected in whole embryos or conditioned medium.
Embryos were injected at the one-cell stage with 300 or 900 pg of RNA encoding
myc-tagged “wild-type” Xlefty or the various cleavage mutants.  Western blot
analysis of cell extracts from whole embryos (A) or conditioned medium from
animal halves (B).  Filled arrowheads, proprotein (P) and XleftyL (L) open
arrowhead, XleftyS (S).  Un, uninjected.
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Cleavage of Xlefty required for Xnr antagonism
     Xlefty inhibits the expression of organizer-specific and mesendodermal genes
that are induced in isolated animal caps by Xenopus Nodal-related factors such
as Xnr2 (Cheng et al., 2000).  To determine if XleftyL, XleftyS and the proprotein
differ in their capacity to inhibit Xnr signaling, we co-expressed normal Xlefty or
its various cleavage mutants with Xnr2.  For wild-type Xlefty, a 1:1 ratio of
Xlefty:Xnr2 RNA resulted in the induction of mesodermal markers (gsc, chd, and
Xbra) at a level similar to or only slightly down-regulated compared to Xnr2
alone.  A higher 10:1 Xlefty:Xnr2 RNA ratio led to suppressed organizer-specific
and pan-mesodermal marker gene expression (Fig. 3.5).  Co-injection of RNAs
encoding Xlefty that should produce only the proprotein (Xleftymcs1/2) or a
proprotein that can be cleaved only to XleftyS (Xleftymcs1) were incapable of
blocking Xnr2-mediated induction of mesodermal markers, even at the 10:1 ratio
(Fig. 3.5A, B).  In contrast, RNA that encoded a protein only capable of cleavage
to XleftyL inhibited Xnr2 function as efficiently as did wild-type Xlefty (Fig. 3.5C).
The difference in Xnr-blocking ability is not explained by different translation
efficiencies, as the level of protein produced from injected myc-tagged RNAs
encoding Xlefty and the various cleavage variants were similar in whole embryos
or when secreted from animal halves (Fig. 3.4).  These results suggest that
cleavage of Xlefty proprotein to XleftyL is required to block Xnr signaling, a
finding consistent with the requirement of proprotein cleavage of mouse Lefty 1
and mouse Lefty 2 to block Nodal signaling in luciferase assays (Sakuma et al.,
2002).
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Figure 3.5 Inhibition of Xnr2 by XleftyL.  A: One-cell stage embryos were
injected with RNA (pg/embryo indicated) encoding Xnr2 plus or minus Xlefty or
Xleftymcs1, the latter to enforce XleftyS production.  Animal caps were analyzed at
stage 10.5 for organizer-specific (goosecoid and chordin) or pan-mesodermal
markers (Xbra).  Odc, loading control.  B, C: Similar analysis of one-cell stage
embryos overexpressing uncleavable Xlefty proprotein (B, Xleftymcs1/2 RNA used)
or proprotein that enforces XleftyL production (C, from Xleftymcs2 RNA) on Xnr2-
mediated mesoderm induction.  WE, whole embryo plus (+) and minus (-)
reverse transcriptase (RT); AC, uninjected animal cap; 1:1, 10 pg of each RNA;
10:1, 100 pg of RNA encoding Xlefty or cleavage mutant protein, and 10 pg of
Xnr2 RNA.
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No dorsal-ventral difference in Xlefty processing
     Tanegashima et al. (2000) demonstrated that Xlefty was unable to inhibit the
Xnr1-mediated induction of mesodermal markers in animal caps, while it could
completely suppress the Nodal-induced expression of chordin in ventral marginal
zone explants.  One interpretation of their data is that SPC enzyme activity could
vary throughout the embryo.  We have been interested in the idea that a dorsal-
to-ventral gradient of Xlefty-processing activity in the gastrula-stage embryo
might be set up as a consequence of the reported dorsal-to-ventral gradient of
Nodal signaling (Lee et al., 2001).  We assayed Xlefty processing in dissociated
animal hemispheres from embryos in which Xleftymyc RNA was targeted to either
both dorsal, or both ventral, blastomeres at the 4-cell stage.  The animal half
conditioned medium (removed at St. 8.5 to 9, cultured for 3 hours; approx.
equivalent of sibling stage 10-10.5) and whole Stage 10-10.5 embryo extracts
were analyzed by western blot.  There was equivalent accumulation of XleftyL
from embryos producing Xlefty from either the dorsal or ventral side (Fig. 3.6).
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Fig. 3.6 Absence of dorsal-ventral difference in Xlefty processing.  Western
blot, cell extracts from embryos (WE) and conditioned medium from dissociated
animal halves (AH) from embryos injected in either both dorsal (D) or ventral (V)
blastomeres at the 4-cell stage with 150 pg/cell of Xleftymyc RNA.  The
completeness of processing to XleftyL at this 300 pg total RNA dose is similar to
that seen at 300 pg/embryo in Figure 3.4.  Un, uninjected embryos; L (solid
arrowhead), XleftyL; proprotein (P) and XleftyS (S) open arrowhead.
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Xlefty does not induce prolonged MAPK activation
     Despite the demonstration above that proprotein cleavage seems to be
required for Xlefty activity, at least as related to Nodal signaling, we were
interested in following up, but this time in a homologous embryonic tissue, a
previous report that human Lefty proprotein showed some biological activity as
an inducer of the MAP kinase pathway in P19 mouse embryonic carcinoma cells
(Ulloa et al., 2001).  To test if either Xlefty or the full-length proprotein caused
prolonged MAPK activation, we assayed for intracellular diphosphorylated
ERK1/2 (dpERK) in whole embryos and animal caps injected with Xlefty and
Xlefty
mcs1/2 RNAs.  Uninjected embryos showed no detectable dpERK at stage 9,
consistent with previous reports (LaBonne and Whitman, 1997; Christen and
Slack, 1999).  However, as expected, wounding (cutting the embryo into
quarters) resulted in robust ERK activation (LaBonne and Whitman, 1997;
Christen and Slack, 1999; Kuroda et al., 2005).  Injection of 100 pg of either
Xlefty or Xleftymcs1/2 RNAs did not induce ERK activation in whole embryos.  In
animal caps isolated from uninjected embryos, surgical removal of the animal
cap, which induces a wounding response, resulted in detection of dpERK, but
this activation was short-lived, becoming barely detectable after 120 minutes.  In
animal caps removed from embryos that were injected with Xlefty or Xleftymcs1/2
RNAs, the steady-state level of dpERK became progressively reduced at a rate
similar to that in animal caps isolated from uninjected embryos (Fig. 3.7).  These
results suggest that neither Xlefty, nor the forcibly overexpressed uncleavable
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proprotein, are capable of inducing prolonged activation of the MAPK pathway in
the homologous context of the Xenopus embryo.
61
Figure 3.7  Xlefty does not induce prolonged MAPK activation.  Western blot
of cell extracts from embryos and animal caps injected with 100 pg of either
Xlefty or Xleftymcs1/2 RNA, using antibodies against diphospho-ERK1/2 or total
ERK1/2.  Time after wounding (“w”; quartering of embryos) or animal cap
isolation is given in minutes.  Un, uninjected; WE, whole embryo; AC, animal cap.
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Glycosylation not required for Xlefty stability
     Several reports suggest that the addition of carbohydrate moieties affect the
secretion, stability and biological activity of TGF family molecules.  For TGF1
and TGF2, blocking N-linked glycan addition by either mutating asparagine
residues, or adding tunicamycin to the culture medium, resulted in no detectable
proprotein or ligand being secreted from COS, 293S or CHO cells (Sha et al.,
1989; Brunner et al., 1992; Lopez et al., 1992).  In addition, tunicamycin
treatment resulted in the intracellular accumulation of the TGF1 proprotein (Sha
et al., 1989).  Active Nodal ligand has been notoriously difficult or impossible to
detect in conditioned medium from COS1 or 293T cells (Constam and
Robertson, 1999; Le Good et al., 2005), but a modified version created by the
insertion of an artificial N-linked glycosylation site into the ligand region (the
glycosylation motif was the same as that in Xnr1/Xnr2/Xnr3) increased the
stability of mouse Nodal (Le Good et al., 2005).  Given that the above reports
suggested that glycosylation was playing a role in secretion and/or stability of
TGF-related molecules, we next determined if glycosylation influenced Xlefty
secretion and stability.  In the context of either wild-type or Myc epitope-tagged
Xlefty, the latter having a similar level of function to the wild-type protein as
explained below, the asparagine in the N-linked glycosylation motif (NRT) was
mutated to either alanine (XleftyNGM-A) or serine (XleftyNGM-S) to prevent N-linked
glycan addition (Brunner et al., 1992; Carter et al., 2005).  The equivalent
migration characteristics of untagged versions of either XleftyNGM-A or XleftyNGM-S
in the presence or absence of tunicamycin showed that these mutations blocked
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addition of all N-linked glycans (Fig. 3.8A).  Dissociated animal halves were used
to test the stability of myc-tagged Xlefty compared to myc-tagged XleftyNGM-A.  As
judged by the equivalent accumulation of Xleftymyc and XleftyNGM-Amyc,
glycosylation does not alter the stability or secretion of Xlefty from embryonic
tissues (Fig. 3.8B).  Also, data gathered from mesoderm induction assays
suggest that the glycosylation mutant is an effective blocker of Xnr2, which
argues for no difference in protein stability compared to wild-type (Fig. 3.9).
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Fig 3.8  Glycosylation not required for protein stability.  A: Xenopus oocytes
were injected with RNA encoding Xlefty or either non-glycosylatable mutant,
XleftyNGM-A or XleftyNGM-S.  Arrowheads, XleftyL and XleftyS.  B: Western blot,
conditioned medium from animal halves from embryos injected at the one-cell
stage with 100, 500, or 1500 pg of Xleftymyc or XleftyNGM-Amyc RNA.  Filled
arrowheads, proprotein and XleftyL; open arrowhead, XleftyS. Un, uninjected
oocyte or embryo; Vehicle, 1% DMSO; (-) conditioned medium from oocytes not
injected with tunicamycin; T, tunicamycin; L, XleftyL; S, XleftyS; P, proprotein.
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Glycosylation of Xlefty not required for Xnr antagonism
     Artificial glycosylation of mouse Nodal greatly increased its signaling activity
compared to the wild-type ligand (Le Good et al., 2005).  Since the stability of
Xlefty secreted from embryonic tissue was not altered by glycosylation, we tested
if glycosylation affected its ability to block Xnr signaling.  Untagged versions of
Xlefty or XleftyNGM-A/XleftyNGM-S RNAs were co-injected with Xnr2 RNA at the
one-cell stage, and the induction of mesodermal markers in animal caps was
analyzed.  Similar to wild-type Xlefty, XleftyNGM-A and XleftyNGM-S efficiently
blocked Xnr2-induced mesodermal gene expression, and we conclude that
glycosylation does not alter the efficacy of Xlefty as an antagonist of Xnr
signaling in mesoderm induction assays (Fig. 3.9) in which the distribution of
Xlefty RNA amongst all animal cap cells effectively removes any potential effect
from the range of movement of the inhibitor (a “range-independent” assay).
66
Fig 3.9 Glycosylation is not required to suppress Xnr2-mediated mesoderm
induction. A: Mesoderm induction assay for effectiveness of non-glycosylated
Xlefty.  Marker expression was assayed at stage 10.5 in animal caps explanted
from embryos injected with Xnr2 (pg/embryo indicated) with or without RNA
encoding Xlefty, XleftyNGM-A, Xleftymyc or XleftyNGM-Amyc.  B: Animal caps were
isolated from embryos injected with Xnr2 (pg/embryo indicated) plus or minus
Xlefty or XleftyNGM-S RNA.  WE, whole embryo plus (+) and minus (-) reverse
transcriptase (RT); AC, uninjected animal cap.  1:1, 10 pg of each RNA; 10:1,
100 pg of RNA encoding untagged or tagged versions of Xlefty, XleftyNGM-A or
XleftyNGM-S and 10 pg of RNA encoding Xnr2.
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Glycosylation does not alter the movement through embryonic tissues
     Interaction with heparan sulfate proteoglycans (HSPGs) has been suggested
to regulate the movement of BMP-4 and Dpp in Xenopus embryonic tissue and
Drosophila imaginal discs, respectively (Ohkawara et al., 2002; Belenkaya et al.,
2004; Han et al., 2004).  Since glycosylation of Xlefty did not alter protein stability
in embryonic tissues or its biological activity in antagonizing mesoderm induction,
we next tested for an effect on the movement of Xlefty.  For range of movement
experiments, we utilized myc-tagged versions of Xlefty and XleftyNGM-A, which
antagonize Xnr2 signaling as effectively as the untagged proteins (Fig. 3.9).
Xlefty
myc or XleftyNGM-Amyc were co-injected with LacZ RNA, encoding nuclear-
targeted -galactosidase as a lineage tracer, into a single marginal blastomere of
32-64 cell-stage albino embryos.  The embryos were analyzed at later stages by
Myc immunostaining.  In uninjected and control-injected embryos (untagged
Xlefty RNA), no specific staining was detected.  In embryos injected with either
Xlefty
myc or XleftyNGM-Amyc, external observation of whole embryos showed a
specific immunostaining reaction that appeared discontinuous and localized to
the interstitial spaces between cells, as opposed to a smoothly distributed signal
(Fig. 3.10A-D).  The distance that Xleftymyc and XleftyNGM-Amyc moved from the
source of production was assessed by counting the maximal observable number
of cell widths of visible signal from the edge of the clone of producer cells
(measured on the vegetal aspect, in the direction of the vegetal pole; single
measurement per embryo; Table 3.1).  Among three independent injection
experiments, the inferred range of movement away from the source cells, as
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assessed at stage 9, was similar between wild-type and non-glycosylated Xlefty.
We also collected embryos at 1, 2, 3, and 4 hours after injection that were then
bisected through the patch of marked producer cells prior to Myc immunostaining
in order to observe the internal signal (Fig. 3.10E-F).  The signal was now
intracellular as well as in the interstitial spaces, but the distal-most point of signal
from the marked clone of producer cells still seemed to be marked by an
extracellular or interstitial signal.  As with the surface Myc staining, there was no
difference at any time point in the distance that wild-type Xlefty and XleftyNGM
moved from the source cells.
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Fig 3.10  Range of Xlefty movement is not altered by glycosylation.  A-H:
Embryos co-injected with 250 pg of LacZ RNA plus or minus 150 pg of tagged or
untagged RNAs encoding Xlefty and XleftyNGM-A and stained for Red-Gal and
then Myc-immunostained.  A-D: Dashed line, boundary of Red-Gal lineage-label-
marked producer cell clone.  Broken arrow, direction of vegetal pole.  Specific
Myc immunodetection signal is purple (arrowhead).  A-D: Embryos were
visualized externally after staining in whole-mount.  Embryos were uninjected (A),
or received 150 pg untagged Xlefty RNA (B), 150 pg Xleftymyc RNA (C), or 150 pg
Xlefty
NGM-Amyc RNA (D).  E-H: Embryos were bisected through the patch of Red-
Gal staining before myc immunostaining.  Embryos were uninjected (E) or
received 150 pg untagged Xlefty RNA (F), 150 pg Xleftymyc RNA (G), or 150 pg
Xlefty
NGM-Amyc RNA (H).
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Table 3.1  Range of movement is not altered by glycosylation
RNA 1 2         3
n average cells p n average cells p n average cells p
Xlefty
myc
17 6.65 ± 2.2 0.103 21 5.28 ± 1.6 0.225 8 6.75 ± 2.1 0.613
Xlefty
NGM-Amyc
16 5.40 ± 2.0 17 6.00 ± 1.9 9 7.33 ± 2.5
150 pg of either Xleftymyc or XleftyNGM-Amyc RNAs were co-injected with 250 pg of RNA
encoding nuclear-localized -galactosidase into one marginal blastomere of a 32-64
cell-stage embryo. Cell widths were calculated as described in the text.  Three
independent experiments (1, 2, and 3) were performed.  n, number of embryos scored.
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Discussion
     In this study, we demonstrated that various vertebrate Lefty molecules were
secreted as glycoproteins from oocytes and that Xlefty was glycosylated when
secreted from embryonic cells.  While all vertebrate Lefty proteins contain a
single N-linked glycosylation motif in the mature region, our data suggest that, at
a gross level, glycosylation does not influence protein stability, Nodal-blocking
function, or its movement through embryonic tissues.
     We showed that Xlefty is capable of being cleaved to produce both long and
short isoforms in oocytes, although efficient cleavage at CS2 may be regulated
by cleavage at CS1.  XleftyL was the only isoform detected, however, when
produced from embryonic cells and seems to be the inhibitory isoform in
mesoderm induction assays.  These findings lead to the conclusion that future
biochemical experiments should be sure to employ the XleftyL isoform in, for
example, determining which region(s) of Xlefty binds to either the Nodal ligand or
xCR1-3 to antagonize Nodal signaling (Chen and Shen, 2004; Cheng et al.,
2004; Tanegashima et al., 2004).  Additionally, determining the binding constants
for the interaction of XleftyL with xCR1-3 or Xnr ligands, by producing stable
XleftyL from an Xleftymcs2 construct, may determine the level to which each
mechanism contributes to the antagonism of Nodal signaling.
     Although the movement characteristics of mouse Lefty 2 and mouse Nodal
have been analyzed by expressing EGFP-tagged proteins in chick mesoderm,
the movement of XleftyL in relation to the various Xnrs should be compared in
Xenopus tissues, where localized injections can be performed to determine how
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Xlefty shapes the Xnr morphogen gradient (Sakuma et al., 2002).  Since Nodal
signaling is important for both mesendoderm induction and proper establishment
of the Left-Right (L-R) axis during embryogenesis, understanding how Xlefty
shapes the Nodal morphogen gradient during mesendoderm formation might
also be relevant to its role in modulating Nodal signaling during L-R specification
(Wright, 2001; Schier, 2003).  It remains possible that in our range of movement
experiments, we are only detecting a fraction of the Xlefty gradient in regions
where enough protein accumulates to generate a detectable immunostaining
signal, while lower levels are in fact functional beyond these domains.  A similar
problem exists with the published studies on EGFP-tagged TGF-related
molecules (Entchev et al., 2000; Teleman and Cohen, 2000; Sakuma et al.,
2002; Belenkaya et al., 2004; Williams et al., 2004; Nakamura et al., 2006),
which must also rise above a detection threshold that is currently unknown with
respect to the level of the ligand that induces downstream gene pathways.  This
issue is further complicated because the tag location in principle cannot
distinguish between the active or inactive ligands or indeed the proprotein forms.
Relevant to this point, at the doses used for our range of movement assays, the
animal half secretion experiments show that the great majority of the
overexpressed Xlefty is being cleaved to the XleftyL form, as the proprotein is not
detected at this RNA level (Fig. 3.8).
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Cleavage of Xlefty is required to block Xnr signaling but not secretion
     Similar to other TGF molecules, Xlefty required proprotein cleavage to block
Nodal signaling.  In P19 mouse embryonic carcinoma cells, however, human
Lefty A proprotein has been reported to activate the MAPK pathway (Ulloa et al.,
2001).  Mechanistically, this result might be explained by the fact that Lefty
molecules have been shown to associate physically with EGF-CFC family
members (Chen and Shen, 2004; Cheng et al., 2004; Tanegashima et al., 2004)
and that overexpression of FRL1/xCR1 in Xenopus tissues can activate MAPK
(Yabe et al., 2003; Yokota et al., 2003).  Thus, Xlefty engagement of EGF-CFC
co-receptors might lead to MAPK activation.  Additionally, cross-talk between
Nodal and FGF signaling pathways, which is known to occur during
mesendoderm specification, may involve physical interactions between EGF-
CFC, Xlefty and the FGF and Nodal ligands (Mizoguchi et al., 2006; Poulain et
al., 2006).  In our experiments in the context of the Xenopus embryo, however,
we detect no evidence of prolonged activation of ERK1/2 by Xlefty or the
proprotein.  This discrepancy may be related to the different experimental
designs.  Ulloa et al. (2001) incubated P19 mouse embryonic carcinoma cells
with affinity-purified human Lefty A generated from conditioned medium from
transfected human embryonic kidney 293 cells expressing leftyA.  Western blot
analysis was used to confirm that human Lefty A was contained in the eluate, but
the purity of the eluted protein was not verified, and it is hard to rule out the
additional possibility that a protein capable of MAPK activation was co-purified.
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     XleftyL and XleftyS were produced at approximately equivalent levels when
normal (i.e., untagged) Xlefty was produced from oocytes.  However, the lack of
XleftyS accumulation to significant levels when embryonic tissues were analyzed
may indicate that the short isoform is a clearance intermediate that is much less
efficiently eliminated when secreted from oocytes, perhaps related to the
absence of an appropriate SPC produced by oocytes.  Alternatively, the
secondary structure of Xlefty, or the inherent protease sensitivity at each site,
may differ between oocytes and embryonic tissues, such that CS2 cleavage does
not occur in embryonic tissues.  A general conclusion from our studies, therefore,
despite the numerous reported experiments using Xenopus oocytes to infer the
mechanisms regulating the biochemical processing of secreted proproteins (Dale
et al., 1989; Thomsen and Melton, 1993; Jones et al., 1996; Cui et al., 1998; Cui
et al., 2001; Eimon and Harland, 2002; Degnin et al., 2004), is that only
embryonic cells should be used for future studies of Xlefty.
 BMP-4 undergoes an ordered cleavage process that affects the strength
and range of signaling during gastrulation stages in Xenopus.  Cleavage at site 1
(S1) separates the ligand from the prodomain and subsequent cleavage within
the prodomain (at S2) seems to be required in order to disrupt non-covalent
prodomain/ligand interactions, which releases the BMP-4 ligand for productive
receptor engagement (Cui et al., 2001).  When the BMP-4 ligand remained
prodomain-associated, the complex seems to be targeted for efficient
degradation via the lysosomal/proteosomal pathway (Degnin et al., 2004).
Therefore, Degnin et al. (2004) suggested that tissue-specific cleavage at S2
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might contribute to the spatiotemporal regulation of BMP-4 activity.  This
hypothesis was validated by mutating the cleavage motif at S2 in the
endogenous locus of mice, which led to defects being detected in those tissues
that require the highest levels of BMP signaling (Goldman et al., 2006).
     Because XleftyS did not accumulate to detectable levels when secreted from
embryonic tissues, and overexpression of an engineered XleftyS-only-expressing
proprotein did not block Xnr2-mediated mesoderm induction, we hypothesize that
the ordered cleavage of Xlefty, first at CS1 to release the active ligand, and then
at CS2 as a post-secretion clearance mechanism, might regulate turnover of
Xlefty in the extracellular milieu.  Post-secretion CS2 cleavage, from SPC
produced by the same or from nearby cells, has a precedent in the numerous
reports of extracellular cleavage of TGF-related molecules.  For example,
mouse Lefty and Nodal can be cleaved by SPCs secreted from COS-1 cells
(Beck et al., 2002).  Moreover, the idea that proprotein-processing enzymes can
act non-cell-autonomously is supported by the detection of mouse nodal and
spc1/spc4 expression in non-overlapping tissue regions during embryogenesis
(Beck et al., 2002).  Another relevant example is the detection of endogenously
produced SPC6 at the cell surface in adult mouse liver, duodenum and jejunum
(Nour et al., 2005).  A post-secretion, clearance activity of SPC at CS2 on XleftyL
might not be detectable in our secretion assays (i.e., there was no stabilization,
or increased level, of XleftyL from the CS2 cleavage site mutant over the wild-
type protein in, for example, Fig. 3.4B) because movement of XleftyL into the
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culture medium and away from the cell reduces its probability of interaction with
secreted or, in particular, cell-surface-localized SPC.
Glycosylation does not alter Xlefty stability, function or movement through
tissue
     As described in the Introduction of this chapter and in Chapter I, studies of
several TGF molecules suggest that glycosylation functions to increase the
stability of the proprotein/ligand and/or aid in secretion from the producing cells
(Sha et al., 1989; Brunner et al., 1992; Lopez et al., 1992; Le Good et al., 2005).
When the single N-linked glycosylation motif in Xlefty was mutated, the steady-
state level of protein accumulated was similar between Xlefty and XleftyNGM.  In
mesoderm induction assays, N-linked glycosylation was not required for Xlefty to
antagonize Xnr2 signaling.  We cannot yet rule out a role for glycosylation
affecting the biological function of Xlefty, as we still might not have performed the
signaling or movement assays at an appropriate time.  For example,
glycosylation of Xlefty may assist in regulating Nodal/Xnr1 signaling during L-R
specification.
     Vg1 and xBMP-4 have been shown to undergo N-linked glycosylation, but we
are uncertain if such a modification is a general mechanism for the stabilization
of the ligand domain, or if this effect is specific for a subset of the TGF family
(Dale et al., 1989; Degnin et al., 2004).  We are currently testing the role of
glycosylation in regulating the protein stability and signaling strength of the
Xenopus Nodal-related proteins.
78
CHAPTER IV
SUMMARY AND FUTURE AIMS
     Members of the TGF superfamily are key controllers of a variety of cellular
processes that include cell differentiation, proliferation, apoptosis, motility and
adhesion.  A broad range of experiments on the Nodal-related proteins has
demonstrated that they are functionally conserved between vertebrates and
essential for mesendoderm specification and L-R axis formation.  During my
thesis research, I investigated the role of post-translational modifications of
Xlefty, the primary Nodal antagonist, and how these modifications affect its ability
to inhibit Nodal signaling during mesendoderm induction in Xenopus.
Specifically, I wanted to determine why Xlefty contained two potential cleavage
sites in the proprotein.  Are both XleftyL and XleftyS produced in embryonic
tissues?  If so, do XleftyL and XleftyS have the same potency as antagonists of
Nodal signaling?  Moreover, I wanted to determine if the glycosylation motif in the
mature domain of Xlefty was functional allowing the addition of N-linked sugars to
the core protein, as well as to investigate the biological function of this
modification.
     By performing my experiments in Xenopus laevis, which is amenable to both
biochemical analysis of proteins and various embryological manipulations, I was
able to show that Xlefty undergoes proprotein cleavage and N-linked
glycosylation in Xenopus tissues.  Furthermore, I presented data that shows that
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proteolytic cleavage of the proprotein to XleftyL is required for inhibition of Nodal
signaling.  At the end of this chapter, I will switch my focus somewhat and
present preliminary data demonstrating that N-linked glycosylation does not
affect the signaling strength of two Nodal-related proteins, Xnr2 and Xnr5.  Since
many studies have demonstrated that the function of Lefty and Nodal-related
proteins are evolutionarily conserved, my results of Xlefty add significantly to the
knowledge of how post-translational modifications modulate Nodal activity.
Moreover, my findings strongly support the idea that analysis of biochemical
processing of secreted ligands should be performed in the appropriate tissues
and at the relevant developmental time.
Post-translational modifications of Xlefty
Proprotein cleavage of Xlefty
     When I began my thesis research studies in the Wright laboratory, a previous
student, Abby Cheng, had isolated and performed the initial characterization of
Xlefty as a feedback inhibitor antagonist of Nodal signaling (Cheng et al., 2000).
Proteolytic cleavage of the Xlefty proprotein could generate two isoforms, which
might have differed properties with respect to the antagonizing of Nodal
signaling. The central issue addressed in my thesis research was the
determination of how biochemical processing (proprotein cleavage and
glycosylation) of Xlefty influenced its ability to regulate Nodal signaling.
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     When Xlefty was produced in Xenopus oocytes, proprotein cleavage occurred
at both CS1 and CS2, although CS2 processing occurred at a low efficiency in
the absence of CS1 cleavage.  This result could be interpreted as indicating that
CS2 cleavage is regulated by cleavage at CS1.  Such sequential cleavage would
be a situation reminiscent of BMP-4, as described in Chapter I and Chapter III.
But in the case of BMP-4, which is an inducer, the second cleavage disrupts a
ligand/prodomain complex that allows for secretion of the ligand to activate
downstream signaling.   In the case of Xlefty, my data suggest that XleftyL is the
functional blocker and that XleftyS (produced by CS2 cleavage following CS1)
might be part of a clearance mechanism to fine-tune the level of Lefty, and thus
Nodal signaling present in the embryo.  We only detected XleftyL, which is
generated from cleavage at CS1, when we assayed embryonic cells isolated at a
stage when Xlefty is normally expressed.  The reason why we did not detect
XleftyS when secreted from embryonic cells might be explained by inappropriate
or extremely high SPC protease activity in oocytes, which leads to improper CS2
cleavage.  Furthermore, XleftyS might be more stable in the oocyte situation, i.e.,
the components of the clearance machinery may not be present in the oocyte.
Alternatively, SPCs may be unable to access CS2 when Xlefty is produced in
embryos, which could be caused by different secondary branching of the sugar
side chains on Xlefty when produced in oocytes versus embryonic cells.  The
idea that glycans can mask CS2 seems unlikely, as we do not detect XleftyS
when XleftyNGM-Amyc was secreted from embryonic cells.  Future studies should
be designed to ascertain the basic secondary structure of the N-linked glycans
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attached to Xlefty and determine if the secondary carbohydrate branching is the
same when Xlefty is secreted from oocytes or embryonic tissues.  Although the
Wright lab is not in a position to pursue these experiments, a combination of
high-performance liquid chromatography and mass spectrometry could be used
for the structural analysis of these carbohydrate moieties.  Further biochemical
analysis should include assays to determine whether XleftyS is produced at
detectable levels in any other specific stage of development, such as, for
example, tailbud stages when Xlefty functions to modulate Nodal signaling during
L-R axis formation.  This experiment could be performed by injecting pCSKA-
Xleftymyc, a plasmid utilized to drive expression of Xleftymyc after gastrulation, into
the left four blastomeres of 8-cell stage embryos.  After the embryos develop to
tailbud stages, the careful isolation of left LPM tissue from uninjected and
plasmid injected embryos for western blot analysis could show if XleftyS
accumulates at the stages, suggesting regulated cleavage at different stages
could alter the effectiveness of Xlefty as a Nodal antagonist.
     Data in Chapter III illustrated that proprotein cleavage of Xlefty was required
to inhibit mesendoderm induction initiated by Xnr signaling, which is consistent
with the requirement for cleavage of mouse Lefty 1 and Lefty 2 in order to block
Nodal signaling (Sakuma et al., 2002).  Unlike mouse Lefty 1, in which both long
and short isoforms effectively inhibited Nodal signaling when expressed in
Xenopus animal caps, injection of Xleftymcs1 RNA designed to be able to produce
only XleftyS could not block Xnr2-mediated induction of mesodermal marker
82
genes.  The most parsimonious explanation for this result is that XleftyS is never
produced in embryonic tissues.
     While XleftyS may not play a role in mesoderm induction, we do not know if
the short isoform functions during L-R specification stages to negatively influence
Nodal signaling.  If XleftyS is produced during tailbud stages, there is a possibility
that XleftyS associates with xCR2, the only EGF-CFC family member expressed
during stages of L-R axis specification, to terminate Xnr1 signaling in the left LPM
(Dorey and Hill, 2006; Onuma et al., 2006).  Future analysis should include
tissue-grafting assays pioneered by Yuki Ohi, a former graduate student (Ohi and
Wright, 2007).  In this assay, LPM tissue overexpressing normal Xlefty, when
transplanted into the left LPM of host embryos, was able to suppress Xnr1
signaling and block the anteriorward progression of Xnr1 expression (Ohi and
Wright, 2007).  A similar experimental design could be performed but now with
tissue overexpressing XleftyS from a plasmid encoding Xleftymcs1, a cleavage
mutant version that should be capable of producing the short isoform.
     The endogenous SPC(s) responsible for proteolytic cleavage of vertebrate
Lefty molecules is/are currently not known.  There are, however, data to suggest
that SPC1, SPC4, and SPC6 mediate proprotein cleavage of Lefty in several
transfected cell lines (Ulloa et al., 2001; Beck et al., 2002; Sakuma et al., 2002).
While these in vitro assays are useful in determining which SPCs can cleave
Lefty in an overexpressed, and perhaps non-physiological situation.  These
assays may not be relevant to the endogenous enzyme produced and functional
in the normal embryonic environment and stage in which Lefty and Nodal
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operate.  The problem of studying proteolytic cleavage of TGF molecules in a
non-physiological assay is illustrated by the fact that Activin was cleaved by
recombinant but not endogenous SPC4 (Cui et al., 1998; Birsoy et al., 2005).  In
the experiment utilized in determining that Activin was not an enzymatic
substrate for endogenous SPC4, spc4 mRNA was depleted by injecting
antisense oligonucleotides into Xenopus oocytes, which were transferred to
recipient Xenopus females (Birsoy et al., 2005).  Following fertilization, embryos
were injected with a RNA encoding an epitope-tagged version of Activin.
Western blot analysis of Activin processing activity was performed on blastocoel
fluid and was compared between normal (not injected with oligonucleotides
targeted against spc4) and spc4 depleted embryos.  In order to establish a full
detailed mechanistic understanding of the way in which Lefty inhibits Nodal
signaling activity, future analyses would therefore be expected to include
experiments to determine which SPC(s) is the endogenous enzyme responsible
for Xlefty cleavage.  In one approach, antisense phosphorothioate
oligonucleotides, which are resistant to nucleases, will be injected into Xenopus
oocytes to deplete specific spc mRNAs and then transferred to recipient females
for fertilization.  Western blot analysis of conditioned medium would then be used
to compare the cleavage products of Xlefty produced from spc-deficient embryos
and embryos not injected with spc oligonucleotides. This type of experiment has
already been performed in Xenopus to analyze some of the biological substrates
of SPC4 and should be relatively straightforward (Birsoy et al., 2005).
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Xlefty is N-glycosylated
     The addition of N-linked glycans to core proteins is an energy and time
consuming process (Jones et al., 2005).  The process involves the ATP-
dependent generation of the dolichol-phosphate acceptor, to which seven sugars
are added on the cytoplasmic face of the endoplasmic reticulum (ER) (Helenius
and Aebi, 2004).  This dolichol-heptasaccharide precursor undergoes a
topological flipping such that the sugar residues are now facing the lumen of the
ER. The seven sugar precursor is extended to 14, and this “full precursor” is
transferred as a core oligosaccharide unit onto the nascent polypeptide chain
(Helenius and Aebi, 2001).  The basic oligosaccharide is then extensively
modified by removing and adding sugar residues in the ER and Golgi complex
(Helenius and Aebi, 2001).  The modification of the N-linked glycans results in
three general categories of oligosaccharides (high-mannose, hybrid, and
complex glycans) with distinct functions (Helenius and Aebi, 2001).  For example,
high-mannose glycans can be further modified to mannose-6-phosphate, a
moiety that functions to target proteins to the lysosome (Helenius and Aebi,
2001).
     As stated in Chapter I and Chapter III, the presence of N-linked glycans can
affect numerous biological processes.  The presence of a conserved N-linked
glycosylation site in the mature domain of Lefty raised the possibility that
carbohydrate moieties influence protein secretion, biological activity and/or
movement through embryonic tissues.  There are several reports of glycosylation
effects on the TGF family, such as TGF1, TGF2, and Nodal.  All vertebrate
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Lefty molecules contain a single N-linked glycosylation motif in the mature
domain.  Furthermore, the placement of this motif is conserved at approximately
20 amino acids downstream of CS2.  For this reason, I wanted to ask whether N-
linked glycans could be added to Xlefty as well as to define the biological role for
this modification.  In the case of TGF1 and TGF2, blocking the addition of N-
linked glycans by either mutating asparagine residues or adding tunicamycin to
the culture medium resulted in a block to secretion and led to intracellular
accumulation of the proprotein (Sha et al., 1989; Brunner et al., 1992; Lopez et
al., 1992).  It is possible that N-linked glycans are required for proper protein
folding and that non-glycosylated TGF1, which does not reach the normal
conformation, is retained in the ER for eventual degradation (Helenius and Aebi,
2004).  Furthermore, N-linked glycans have been shown to positively influence
several biological attributes of mouse Nodal.  For example, the insertion of an
artificial glycosylation site (to mimic the site found in several Xnr ligands, as
described in more detail below) into mouse Nodal resulted in increased steady-
state protein levels when secreted from cultured cell lines, and signaling strength
in activating Nodal-response genes in zebrafish embryos compared to the wild-
type protein (Le Good et al., 2005).
     The data presented in Chapter III demonstrate that Xlefty was N-glycosylated
when secreted from animal halves, but that glycosylation did not influence the
steady state level of protein accumulation, Nodal-inhibitory function during
mesoderm induction, or long-range movement through Xenopus blastula stage
tissues.  Future analysis should include assays to determine if sugars residues
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alter the intrinsic protein half-life of Xlefty in its normal embryonic context, which
could be done by pulse-chase experiments.  These experiments are not trivial to
perform in Xenopus, because it is well known that these large embryos contain
massive stores of RNAs and amino acids deposited during oogenesis. The
difficulty arises from the principles of the pulse-chase type assay.  In this
analysis, there is a depletion of a precursor (amino acids or RNAs) pool, which is
followed by a short labeling time with radioactive precursor.  Next, the non-
radioactive amino acids or RNAs are added to reconstitute the large pool.  The
amount of labeled protein or RNA is followed in time, and how it decays or
becomes converted into specific cleavage products, is then determined.  While
radioactive amino acids can be incorporated into Xenopus embryos to a level
that allows detection, the specific activity of the labeled protein is often low and
variable, and the amount that needs to be added results in the post-pulse being
difficult to attain properly.
     As mentioned above, Xlefty is thought to function as a long-range feedback
inhibitor of Xnr1 during the process of L-R axis specification in Xenopus embryos
and the glycosylation state may positively or negatively influence its range of
movement through the left LPM.  This issue could be addressed using the
techniques of Ohi and Wright (2007) by transplanting LPM tissue overexpressing
Xlefty
myc or a glycosylation mutant version of Xlefty (XleftyNGMmyc) [which are
known to have equal functions as Xlefty; they antagonize Xnr signaling as
effectively as the untagged proteins as measured by the suppression of Xnr2-
mediated induction of mesodermal marker genes] into the left LPM of host
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embryos.  After the embryos reach tailbud stage, they could be fixed at various
time points for immunohistochemical analysis with an anti-myc antibody. The
result of this experiment might determine how glycosylation influences the
movement of Xlefty through the LPM.  Furthermore, the route that Xlefty travels
within the embryo during tailbud stages is unknown.  Based on the low resolution
histological analysis of neurula and tailbud stage embryos, the LPM consists of
more than one cell layer sandwiched between the overlying ectoderm and the
adjacent endoderm (Hausen and Riebesellm, 1991).  There could be several
potential paths that Xlefty could utilize for its long-range movement through the
embryo to attenuate Nodal signaling.  For example, Xlefty could travel through
the interstitial space between cells in the plane of the LPM.  Alternatively, there
could be space between the LPM and endoderm (or ectoderm) through which
Xlefty travels. Glycans present on Xlefty may influence that course and speed of
movement though the LPM or embryonic tissues at these later stages.
Xlefty is Nodal-specific antagonist
     While the general consensus is that a principal conserved function of Lefty is
a feedback inhibitor of Nodal signaling during mesendoderm induction and L-R
patterning in vertebrate embryos, there are a few reports that suggesting that
Lefty molecules can function in other signaling contexts.  Furthermore, there are
data to suggest that signaling pathways other than Nodal can induce the
transcription of lefty.
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     Initially, mouse Lefty 1 was isolated from a subtractive hybridization screen
trying to identify genes that were regulated by the transcription factor Oct-3 in
P19 embryonic carcinoma cells (Meno et al., 1996).  Subsequently, a second
isoform was discovered in mouse by similarity-based methods (Meno et al.,
1997).  Concurrent with these studies, Oulad-Abdelghani et al. (Oulad-
Abdelghani et al., 1998) also isolated mouse lefty 1 as a retinoic acid-induced
gene in P19 embryonic carcinoma cells (Oulad-Abdelghani et al., 1998).
     Prior to defining the function of Lefty molecules as an inhibitor of Nodal, Lefty
was thought to be an anti-BMP molecule.  This idea came from experiments
overexpressing BMPprodomain-Leftymature chimeric proteins in Xenopus animal caps,
which led to a neuralized phenotype (Meno et al., 1997).  However, when normal
Xlefty was overexpressed in animal caps, there was no induction of neural
markers (Cheng et al., 2000).  These conflicting results might be explained by
results from Daniel Constam and colleagues.  They demonstrated that the
prodomains of TGF-related factors can influence the stability of the mature
domains (Constam and Robertson, 1999).  Thus, it is possible that the
prodomain from the chimeric protein mediates an inappropriate association with
the ligand domain of endogenous BMPs, generating a complex that was unable
to initiate downstream signaling.  This neuralized phenotype was the result of
diminished BMP signaling, which directed animal caps down the default neural
induction program (Kuroda et al., 2005).
     Recently, another function has been ascribed to Lefty molecules.
Overexpressed Human Lefty molecules (both the proprotein and the mature
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domain) could apparently induce the MAP Kinase pathway in P19 mouse
embryonic carcinoma cells (Ulloa et al., 2001).  However, in my experiments that
directly addressed this issue by overexpressing Xlefty in Xenopus tissue, I could
not detect MAPK activation.  The reason for this inconsistency is not known but
could relate to the way Lefty was produced in their assay. Ulloa et al. (2001)
incubated P19 mouse embryonic carcinoma cells with affinity-purified human
Lefty A generated from conditioned medium from transfected human embryonic
kidney 293 cells expressing leftyA and while western blot analysis confirmed the
presence of human Lefty A in the eluate, its purity even after partial “affinity”
purification was not verified.  It is, therefore, possible that a protein capable of
MAPK activation was co-purified.
     Despite these few reports that Lefty might be a multifunctional protein (anti-
BMP and inducer of MAPK), the overwhelming weight of data being to work as a
Nodal-inducible feedback antagonist of the Nodal auto-regulatory signaling loop,
is in agreement with the primary role of Lefty is that of a Nodal antagonist.
Does glycosylation regulate Xnr signaling?
     In the previous sections of this thesis, I have been discussing how post-
translational modifications influence the ability of Xlefty to modulate Xnr
signaling.  In this section, I begin to change the focus from the antagonist and
move onto explorations of the effect of N-linked glycosylation on the activities of
the inducers themselves; specifically the Xnr ligands.  As discussed in Chapter I
and Chapter III, when mouse Nodal was created by inserting an artificial
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glycosylation site into the ligand domain (a site present in five of the six Xnrs), it
had increased signaling strength in zebrafish embryos and stability in culture
cells (Le Good et al., 2005).  The placement of the glycosylation motif is
conserved (five amino acids downstream of the third cysteine residue) in Xnr 1,
2, 3, 4, and 6, but is absent from in Xnr5 (Table 4.1). If the data from Daniel
Constam and colleagues are correct, sugar residues present on the Xnr ligands
should increase the intrinsic protein stability and signaling strength of these
powerful inducers compared to the non-glycosylated version (Le Good et al.,
2005).
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Table 4.1 Alignment of amino acid sequences of Nodal-related proteins
Nodal-related protein Amino acid sequence
Xnr1 C P I P L N E T F K P T
Xnr2 C P I P L N E T F K P T
Xnr3 C A V P Q N E T E N A T
Xnr4 C P S P V N E S V K P N
Xnr5 C P I P L D E N F K P T
Xnr6 C P I P L N E S F K P T
Nodal C P N P V G E E F H P T
Cyclops C P N P L G E E L R P T
Squint C P T P V D E T F T P T
Southpaw C P S P L D E T Y N P T
Alignment of Xnr1 residues 339-350 and the corresponding sequences from the
Nodal-related proteins from Xenopus, mouse, and zebrafish.  Putative N-
glycosylation sites are boxed in yellow.
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     For simplicity, I selected two Xnrs (Xnr2 and Xnr5) for these studies.  In order
to test the biological function of these N-linked glycans, I used site-directed
mutagenesis to remove the glycosylation motif in Xnr2 and add the N-E-T
consensus site to Xnr5 (the N-linked site is at the same location as Xnr1/2/4/6).
Using mesoderm induction assays, we compared the activity of wild-type Xnrs to
the mutant versions (Xnr2 glycosylation mutant, Xnr2NGM; glycosylated version of
Xnr5, Xnr5G).  My preliminary experimental results show that N-linked glycans do
not influence the signaling strength of Xnrs in this range-independent assay, as
the distribution of RNAs amongst all animal cap cells effectively removes any
potential effect from the range of movement of the inducer (Fig. 4.1).  Using
similar experiments described in Chapter III, future analysis will include assays to
determine if glycosylation affects intrinsic protein stability and the movement of
these ligands through blastula stage tissues.
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Fig 4.1 Glycosylation does not alter the signaling strength of Xnr2 and
Xnr5.  A, B: One-cell stage embryos were injected with RNA (pg/embryo
indicated) encoding Xnr2, Xnr2NGM (mutated glycosylation site), Xnr5, or Xnr5G
(inserted glycosylation site).  Animal caps were analyzed at stage 10.5 for
mesodermal marker gene expression. WE, whole embryo plus (+) and minus (-)
reverse transcriptase (RT); AC, uninjected animal cap.
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